JPH0482159B2 - - Google Patents
Info
- Publication number
- JPH0482159B2 JPH0482159B2 JP60138870A JP13887085A JPH0482159B2 JP H0482159 B2 JPH0482159 B2 JP H0482159B2 JP 60138870 A JP60138870 A JP 60138870A JP 13887085 A JP13887085 A JP 13887085A JP H0482159 B2 JPH0482159 B2 JP H0482159B2
- Authority
- JP
- Japan
- Prior art keywords
- renal
- compound
- oih
- magg
- maggg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 claims description 79
- 238000000034 method Methods 0.000 claims description 28
- 239000003446 ligand Substances 0.000 claims description 12
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 5
- 239000000543 intermediate Substances 0.000 claims description 5
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 claims description 4
- 229910006074 SO2NH2 Inorganic materials 0.000 claims description 4
- 229910006069 SO3H Inorganic materials 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- BWLBGMIXKSTLSX-UHFFFAOYSA-N 2-hydroxyisobutyric acid Chemical compound CC(C)(O)C(O)=O BWLBGMIXKSTLSX-UHFFFAOYSA-N 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 3
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 claims description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 3
- FATUQANACHZLRT-KMRXSBRUSA-L calcium glucoheptonate Chemical compound [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O FATUQANACHZLRT-KMRXSBRUSA-L 0.000 claims description 3
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 3
- 235000011180 diphosphates Nutrition 0.000 claims description 3
- 229940050410 gluconate Drugs 0.000 claims description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 3
- 229940095064 tartrate Drugs 0.000 claims description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 claims description 2
- UIJGNTRUPZPVNG-UHFFFAOYSA-N benzenecarbothioic s-acid Chemical compound SC(=O)C1=CC=CC=C1 UIJGNTRUPZPVNG-UHFFFAOYSA-N 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims 1
- 229940048084 pyrophosphate Drugs 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 description 27
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Chemical compound NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 22
- 210000005239 tubule Anatomy 0.000 description 19
- 230000015572 biosynthetic process Effects 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 16
- 238000003786 synthesis reaction Methods 0.000 description 16
- 230000003907 kidney function Effects 0.000 description 15
- 238000005259 measurement Methods 0.000 description 14
- 241000699670 Mus sp. Species 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 210000001124 body fluid Anatomy 0.000 description 12
- 239000010839 body fluid Substances 0.000 description 12
- 230000008060 renal absorption Effects 0.000 description 12
- 230000002485 urinary effect Effects 0.000 description 12
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 11
- 229910052717 sulfur Inorganic materials 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- 229910052708 sodium Inorganic materials 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 238000007487 urography Methods 0.000 description 9
- 239000012530 fluid Substances 0.000 description 7
- 239000012216 imaging agent Substances 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 230000005855 radiation Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- VDPYMEBVIDZKMD-UHFFFAOYSA-N betiatide Chemical compound OC(=O)CNC(=O)CNC(=O)CNC(=O)CSC(=O)C1=CC=CC=C1 VDPYMEBVIDZKMD-UHFFFAOYSA-N 0.000 description 6
- 238000003384 imaging method Methods 0.000 description 6
- 210000002700 urine Anatomy 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 230000029142 excretion Effects 0.000 description 5
- 230000001434 glomerular Effects 0.000 description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 210000000885 nephron Anatomy 0.000 description 5
- IUTCEZPPWBHGIX-UHFFFAOYSA-N tin(2+) Chemical compound [Sn+2] IUTCEZPPWBHGIX-UHFFFAOYSA-N 0.000 description 5
- JDIFMCNVLPJSTJ-UHFFFAOYSA-N 2-[[2-[[2-[(2-chloroacetyl)amino]acetyl]amino]acetyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)CNC(=O)CNC(=O)CCl JDIFMCNVLPJSTJ-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 229960001230 asparagine Drugs 0.000 description 4
- 239000002738 chelating agent Substances 0.000 description 4
- GRWZHXKQBITJKP-UHFFFAOYSA-L dithionite(2-) Chemical compound [O-]S(=O)S([O-])=O GRWZHXKQBITJKP-UHFFFAOYSA-L 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 230000002285 radioactive effect Effects 0.000 description 4
- 239000012217 radiopharmaceutical Substances 0.000 description 4
- 229940121896 radiopharmaceutical Drugs 0.000 description 4
- 230000002799 radiopharmaceutical effect Effects 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- RXACEEPNTRHYBQ-UHFFFAOYSA-N 2-[[2-[[2-[(2-sulfanylacetyl)amino]acetyl]amino]acetyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)CNC(=O)CNC(=O)CS RXACEEPNTRHYBQ-UHFFFAOYSA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 125000004430 oxygen atom Chemical group O* 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- PNDPGZBMCMUPRI-HVTJNCQCSA-N 10043-66-0 Chemical compound [131I][131I] PNDPGZBMCMUPRI-HVTJNCQCSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- NPHIMMUDLMWWKP-UHFFFAOYSA-N 2-[2-[2-hydroxyethyl(methyl)amino]ethylamino]ethanol Chemical compound OCCN(C)CCNCCO NPHIMMUDLMWWKP-UHFFFAOYSA-N 0.000 description 2
- QMOQBVOBWVNSNO-UHFFFAOYSA-N 2-[[2-[[2-[(2-azaniumylacetyl)amino]acetyl]amino]acetyl]amino]acetate Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(O)=O QMOQBVOBWVNSNO-UHFFFAOYSA-N 0.000 description 2
- CORFWQGVBFFZHF-UHFFFAOYSA-M 2-iodohippurate Chemical compound [O-]C(=O)CNC(=O)C1=CC=CC=C1I CORFWQGVBFFZHF-UHFFFAOYSA-M 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 108010001064 glycyl-glycyl-glycyl-glycine Proteins 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 238000009592 kidney function test Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229910001414 potassium ion Inorganic materials 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- JTHUJOZLDHAGIH-UHFFFAOYSA-M sodium;thiobenzate Chemical compound [Na+].[O-]C(=S)C1=CC=CC=C1 JTHUJOZLDHAGIH-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229940056501 technetium 99m Drugs 0.000 description 2
- FCWGKIPTCWLKMY-UHFFFAOYSA-N (2-sulfanylacetyl) 2,3-diaminopropanoate Chemical compound NCC(N)C(=O)OC(=O)CS FCWGKIPTCWLKMY-UHFFFAOYSA-N 0.000 description 1
- UYVWQHGBGGGUQW-UHFFFAOYSA-N 2-[2-[(2-aminoacetyl)amino]acetyl]pentanedioic acid Chemical compound NCC(=O)NCC(=O)C(C(O)=O)CCC(O)=O UYVWQHGBGGGUQW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- CCQOOWAONKGYKQ-BYPYZUCNSA-N Gly-Gly-Ala Chemical group OC(=O)[C@H](C)NC(=O)CNC(=O)CN CCQOOWAONKGYKQ-BYPYZUCNSA-N 0.000 description 1
- KMSGYZQRXPUKGI-BYPYZUCNSA-N Gly-Gly-Asn Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(N)=O KMSGYZQRXPUKGI-BYPYZUCNSA-N 0.000 description 1
- UFPXDFOYHVEIPI-BYPYZUCNSA-N Gly-Gly-Asp Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O UFPXDFOYHVEIPI-BYPYZUCNSA-N 0.000 description 1
- QPTNELDXWKRIFX-YFKPBYRVSA-N Gly-Gly-Gln Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O QPTNELDXWKRIFX-YFKPBYRVSA-N 0.000 description 1
- KAJAOGBVWCYGHZ-JTQLQIEISA-N Gly-Gly-Phe Chemical compound [NH3+]CC(=O)NCC(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 KAJAOGBVWCYGHZ-JTQLQIEISA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- HSMNQINEKMPTIC-UHFFFAOYSA-N N-(4-aminobenzoyl)glycine Chemical compound NC1=CC=C(C(=O)NCC(O)=O)C=C1 HSMNQINEKMPTIC-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- -1 benzoylmercaptoacetylglycylglycylglycine Benzoylmercaptoacetylglycylglycylglycine Chemical compound 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000009206 nuclear medicine Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 210000000512 proximal kidney tubule Anatomy 0.000 description 1
- 230000005258 radioactive decay Effects 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000005227 renal system Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Description
ç£æ¥äžã®å©çšåé
æ¬çºæã¯ã·ã³ãã°ã©ãã€ãŒå°¿è·¯é 圱æ³ãçšããŠ
è æ©èœã調ã¹ãåéã«ãããŠäœ¿çšããæ¹æ³ããã³
ååç©ã«é¢ããããã詳现ã«ã¯ãæ¬çºæã¯ãã¯ã
ããŠã â99mã§æŸå°èœæšèãããã¬ãŒãé¡ã䜿çš
ããããšã«ããè èç³»ã®ã€ã¡ãŒãžã³ã°ïŒæ å圢
æïŒã«é¢ããã åŸæ¥ã®æè¡ äººäœã®æ©èœã«é¢ããåºç€ççåŠã«ãããŠã¯äœæ¶²
ã®æåããã³éã®èª¿ç¯ãéåžžã«éèŠã§ãããäŸã
ã°ã人äœã§ã¯å šäœæ¶²éã现èå€äœæ¶²ã®æåãäœæ¶²
äžã®é žâå¡©åºãã©ã³ã¹ãããã³çŽ°èå€äœæ¶²ãšçŽ°è
å äœæ¶²ã®äº€æã«åœ±é¿ãåãŒãåçš®ã®å åïŒæãé¡
èã«ã¯ããã®ãããªäœæ¶²éã®æµžéé¢ä¿ã«åœ±é¿ãäž
ããå åïŒãªã©ã®äœæ¶²ã«é¢ããå€åã調ç¯ããã
ãšãå¿ èŠã§ããã è èã¯äœæ¶²ã®çµæã®èª¿ç¯ãã€ããã©ãéèŠãªè
åšã§ãããåŸã€ãŠãè èã¯æçµä»£è¬ç£ç©ã®å€§éšå
ãææ³ããã€æãŸããäœæ¶²æåã®æ¿åºŠã調ç¯ãã
ããšã«ãã€ãŠççåŠçã«èš±å®¹ãããç¯å²å ã«äœæ¶²
ãç¶æããã 人äœã¯èè±ãéã€ãŠææ³ãããäœæ¶²æåãå«ã
å°¿ãçæããããã®ïŒåã®è èãæããŠãããè
èã®åããè¡ãçç©åŠçãªåºæ¬åäœãâããã
ã³âã§ãããè èã¯ããããçŽ100äžã®ãããã³
ã§æ§æãããåãããã³ã¯ä»ã®ãããã³ãšã¯ç¡é¢
ä¿ã«äœæ¶²ã調ç¯ããããšãã§ããã è èã¯å®è³ªç容éã®è¡æ¶²ïŒå šæåºéã®çŽ1/5ã
çŽæ¥è èãžéãããïŒãéããããšã«ããäœæ¶²
ã«å¯ŸããŠæ©èœãããã®ç¹å®å®¹éã®è¡æ¶²ã¯âè èç»
åïŒrenal fractionïŒâãšããŠç¥ãããŠãããè¡
液ã¯äžè¬æ人ç·åã®è èãžå¹³åçŽ1.2ïŒåã®æµ
éã§æµãããè¡æ¶²ãè èãééãããšããããã
ã³ã¯äžèŠç©è³ªãäŸãã°æçµä»£è¬ç£ç©ïŒå°¿çŽ ãã¯ã¬
ã¢ããã³ãå°¿é žãç¡«é žå¡©ããã³ããšããŒã«ãªã©ïŒ
ããã³ã€ãªã³æ§é代è¬ç©è³ªïŒéå°ã®ãããªãŠã ã
ã«ãªãŠã ããã³å¡©çŽ ã€ãªã³ãªã©ïŒãè¡æŒ¿ããåã
é€ãã ãããã³ã¯åºæ¬çã«â糞çäœâãšåŒã°ããæ¯çŽ°
è¡ç®¡åºãâ管åšâæ¯çŽ°è¡ç®¡ïŒperitubular
capillaryïŒãšããŠç¥ããã第ïŒã®æ¯çŽ°è¡ç®¡åºã
ããã³â尿现管âãšããŠç¥ãããå°¿çæéšåãã
ãªã€ãŠããã尿现管ã¯â糞çäœèâãšããŠç¥ãã
ãèã«ãã€ãŠç³žçäœããåé¢ããããè¡æ¶²ã®è è
ç»åã糞çäœãééãããšãã糞çäœèã¯è èç»
åãããªãè¡æŒ¿ã®å°éå²åïŒäžè¬ã«ã¯20ã25ïŒ ä»¥
äžïŒã尿现管ãžéãããã®åŸãã®éäœæ¶²ã¯å°¿çŽ°
管ãéã€ãŠè èã®è ã®æ¹ãžæµãããããŠèè±ãžãš
é ã«éã°ãããäœæ¶²ã尿现管ãééãããšãã倧
éšåã®æ°Žã倧éšåã®é»è§£è³ªãããã³ãã®ä»ã®âå¿
èŠâç©è³ªã¯ååžåãããŠè¡æ¶²ãžæ»ããâäžèŠâç©
質ïŒæçµä»£è¬ç£ç©ãéå°ã®æ°Žããã³é»è§£è³ªãªã©ïŒ
ãå°¿ãšããŠææ³ãããããã«èè±ãžéãããã 糞çäœèãééããªãè èç»åã®æ®ãã®éšåã¯
ãã®ç³žçäœã«ãšã©ãŸãããã®åŸç®¡åšæ¯çŽ°è¡ç®¡ãžå ¥
ããããããè èç»åã®äžéšãäžè¬ã«ã¯éèç³»ãž
æ»ãããã尿现管ã§ååžåããã倧éã®äœæ¶²ãå°¿
现管èãéã€ãŠæ¡æ£ã«ãã管åšæ¯çŽ°è¡ç®¡ãžéã°ã
ãã 倧éã®äœæ¶²ã¯å°¿çŽ°ç®¡ãã管åšæ¯çŽ°è¡ç®¡ãžæ¡æ£ã
ãŠè¡ç®¡ç³»ã«æ»ãããè¥å¹²ã®è¡æŒ¿ã¯éæ¹åãããªã
ã¡ç®¡åšæ¯çŽ°è¡ç®¡ãã尿现管ãžã®æ¡æ£ãããããäŸ
ãã°ã尿现管èãéã€ãŠç®¡åšäœæ¶²äžãžãããªãŠã
ã€ãªã³ãèœåçã«éã¶ããšã«ãããã®éèŠãªé»è§£
質ã倱ãããã«ããããäžæ¹ã§ãã®ããšã¯å°¿çŽ°ç®¡
å ã«ç®¡åšäœæ¶²ã«å¯Ÿããå®è³ªçé°é»è·ãçããã
ããè¿äœå°¿çŽ°ç®¡ã«ãããŠã¯ãã®é»äœå·®ãçŽ20ããª
ãã«ãã§ããããããŠé äœå°¿çŽ°ç®¡ã§ã¯ããã120
ããªãã«ãçšåºŠã«äžæãããã ãã®é»äœå·®ã¯ããçš®ã®éœã€ãªã³ïŒæãé¡èã«ã¯
ã«ãªãŠã ã€ãªã³ïŒã管åšäœæ¶²ãã尿现管ãžæ¡æ£ã
ãããé»æ°é°æ§åºŠåŸé ã«ãã尿现管èãçµã尿现
管ãžã®ã«ãªãŠã ã€ãªã³ã®ç§»åã¯âåååæ³
ïŒpassive secretionïŒâãšåŒã°ããã ãã®åååæ³ã«å ããŠãè¥å¹²ã®ã€ãªã³æ§ç©è³ªã¯
尿现管ã®äžãžâèœåçâã«åæ³ããããäŸãã°ã
ãã©âã¢ããéŠ¬å°¿é žïŒäžè¬ã«ã¯PAHãšåŒã¶ïŒã¯
管åšäœæ¶²ãã尿现管ãžèœåçã«åæ³ãããè èç»
åã®çŽ20ïŒ ã®ã¿ã糞çäœæ¶²ãšããŠå°¿çŽ°ç®¡ãžéã
ããã«ãããªããã®ã«ãããããããè¡æ¶²äžã®
PAHã¯ãã®90ïŒ è¿ããè èã«ãã€ãŠé€å»ãããã
åŸã€ãŠãPAHã®çŽ70ïŒ ã¯å°¿çŽ°ç®¡ãžã®èœååæ³ã«
ãã€ãŠè¡æŒ¿ããé€ãããããšã«ãªãã æãããè èãæå·ãåããŠããã®çµæè¡æ¶²æµ
åäœçšãäœäžããããããã¯ãã®æµåäœçšãåæ¢
ããããšããããã ãããçºçããè èã®æå·ã®
çšåºŠãšåãå»åž«ãè©äŸ¡ããã®ãå©ããããã«ãå
çš®ã®è æ©èœè©Šéšãèæ¡ãããããŸãããããã®è
æ©èœè©Šéšã¯è è移æ€æè¡åŸã«è èãé©åã«åããŠ
ãããã©ããã調ã¹ãã®ã«æçšã§ããã ãã®ãããªè æ©èœè©Šéšæ¹æ³ã®ïŒã€ã¯éèå ã·ã³
ãã°ã©ãã€ãŒå°¿è·¯é 圱æ³ãšããŠç¥ããããã®ã§ã
ãïŒãã®æ¹æ³ã¯ãŸãåçè æ©èœã€ã¡ãŒãžã³ã°æ³ãš
ããŠãæ®éã«ç¥ãããŠããïŒããã®æ¹æ³ã¯ããšã
ãšïŒ©â131ãªã«ãâãšãŒãéŠ¬å°¿é žå¡©ïŒïŒ©â
131OIHãšåŒã°ããïŒã®ãããªæŸå°èœæšèãããš
ãŠçŽ ç©è³ªã®éèå æäžããšããªããPAHãšåæ§
ã«ãâ131 OIHã¯ç³žçäœã§ã®éã«å ããŠå°¿
现管ãžã®èœååæ³ã«ãã€ãŠè¡æ¶²ããè¿ éã«é€ã
ãããã®çµææäžåŸïŒãïŒå以å ã«ææéã®æŸå°
èœæšèç©è³ªãè èå ã«æ¿çž®ãããããã®æŸå°èœæš
èç©è³ªã®äœçœ®ã瀺ãããšãã§ããã¬ã³ãã·ã³ãã¬
ãŒã·ãšã³ã«ã¡ã©ã䜿ã€ãŠæ åãåŸãããã«ããè
èã«ãããè æ©èœã®æ¬è³ªãç¥ãããšãã§ããã è æ©èœãè©äŸ¡ããéã«ïŒ©â131 OIHãéèŠãª
æ段ã§ãããšããäºå®ã«ãããããããããã«ã¯
ããã€ãã®æãããªé£ç¹ãååšããããŸã第äž
ã«ããšãŠçŽ â131ïŒïŒ©â131ïŒãé«ãšãã«ã®ãŒã¬ã³
ãæŸå°ç·éïŒ364KeVïŒãæããããã«ãâ
131 OIHã®äœ¿çšã¯ç©ºéçå解ã®ä¹ããæ åãã
ãããããã®ããšã¯è èå ã®çŽ°éšã®èŠ³å¯ãå°é£ã«
ãããã®çµæãã®æ¹æ³ã«ãã€ãŠåŸãããæçšãªæ
å ±éãå¶éãããã ããã«ãâ131 OIHã®è èåžåçïŒè èã
ééããè¡æ¶²ããæŸå°æ§è¬åãåãé€ãèœåïŒã
çŽ65ã80ïŒ ã§ããã«ããããããã¯ããªãããæ¹
ã§ã¯ããããããã«é«ãåžåçã¯ããã«é«ãè è
察åºåºå€ïŒããã¯ã°ã©ãŠã³ãïŒæ¯ããããããŠè
æ©èœã®æ€åºã容æã«ããã ããããŸããâ131
ã¯æŸå°æ§åŽ©å£äžã«ããŒã¿ç²åãæŸå°ããŠåšå²ã®çµ
ç¹ã«æå·ãäžããã ãããããã«ãâ131
OIHã«ä»éããéé¢ã®æŸå°æ§ãšãŠçŽ ã¯æ£è ã®ç²
ç¶è ºã«åžåãããããã®ã§ãâ131 OIHã®æ
倧ç·éãäžè¬ã«çŽ200ã300ãã€ã¯ãããŠãªãŒã«ç¶
æããªããã°ãªããªãããã®äœãæäžéã¯æŸå°æ§
ç»åãåŸãå Žåã«ããªãã®æŽé²æéãå¿ èŠãšãã
è æ©èœæ€æ»äžã«åŸãããé£ç¶ç»åã®æéçå解èœ
ãé 次æžå°ãããã æŸå°ç·ã«ããè æ©èœæž¬å®æ¹æ³ã«ãããŠåŸããã
å解èœãæ¹è¯ããããã«ãå¥ã®æŸå°èœæšèç©è³ªã
ç±å¿ã«æ¢ãæ±ããããŠãããä»æ¥ã§ã¯ãæãæãŸ
ããæŸå°æ§æšèããã¯ãããŠã â99mïŒTcâ
99mïŒã§ãããšèãããããã®Tcâ99mã¯ãã
äœããšãã«ã®ãŒïŒ140KeVïŒã®æŸå°ç·ãæŸå°ãã
ã®ã§ïŒ©â131æšèãšæ¯èŒããå Žåã«ããªãæ¹è¯ã
ããå解ç¹æ§ãæããŠããããã®æ¯èŒçäœããšã
ã«ã®ãŒã®æŸå°ç·ã¯æšæºçãªæŸå°ç·æž¬å®è£ 眮ãšå ±ã«
䜿çšããã®ã«ããé©åãããïŒããªããŠãªãŒåœã
ãã®æŸå°ç·éã¯ïŒ©â131ã䜿çšããå ŽåãããTc
â99mã®æ¹ãã¯ããã«å°ãªãããªããªãâ131
ã®åæžæãïŒæ¥ã§ããã®ã«å¯ŸããŠTcâ99mã®å
æžæã¯çŽïŒæéã§ããã«ãããããŸãTcâ99m
ã¯ãã®åŽ©å£éçšäžã«ããŒã¿ç²åãæŸå°ããªããã
ã§ããã Tcâ99mã®æŸå°èœç¹æ§ã¯æºå®å®æ§ã®å±èµ·ãã
ãååæ žãåºåºç¶æ ã®Tcâ99ãžé·ç§»ããããšã«
èµ·å ãããçããTcâ99ã¯å®è³ªçã«ç¡å®³ã§ãã
ã»ã©ã®é·ãåæžæïŒ200000幎ïŒãæããŠãããã
ã®çµæã30000ãã€ã¯ãããŠãªãŒçšåºŠã®Tcâ99m
ãæ£è ã«å±éºãäžããããšãªãæäžãåŸããåŸã€
ãŠïŒ©â131 OIHã䜿çšããå Žåãããããªãç
ãæŽé²æéã§ãã¿ãããã«ããæŸå°æ§è¬åãè è
ãæåã«ééããéã«èš±å®¹ã§ããæœ æµæ å
ïŒperfusion imageïŒãåŸãããšãã§ããã Tcâ99mã®äžèšç¹æ§ã¯ããããæšæºè£ 眮ãšå ±
ã«äœ¿çšããã®ã«ããé©åããã€ããã䜿çšããæ£
è ã«æ¯èŒçäœãæŸå°ç·éãäžããã®ã§ãæ žå»çã«
ãããïŒã€ã®æ段ãšããŠçæ³çã§ããã â131æšèãšæ¯ã¹ããšãã®Tcâ99mæšèã®äž
èšå©ç¹ããã«ãé«ãè èåžåçãæããTcâ
99mååç©ã®éçºã«å¯ŸããŠå€å€§ã®åªåãæãããŠ
ãããå€æ°ã®Tcâ99mã§æšèããããã¬ãŒãé¡
ãæç®äžã«å ±åãããŠããã Tcâ99mæšèååç©ã®ïŒã€ãšããŠTcâ99mãž
ãšãã¬ã³ããªã¢ãã³äºé ¢é žïŒäžè¬ã«Tcâ99mâ
DTPAãšåŒã¶ïŒãã³ãŸãã«ã«ããã·ã¬ãŒãããž
ã«ã«ããã·ã¬ãŒããããã³ãã³ãŸã«ã«ããã·ã¬ãŒ
ãé¡äŒŒäœãåæãããŠãã€è©Šéšãããã ãããã®ãã¡ã§æãå¹çããææ³ãããé¡äŒŒäœ
ã¯Tcâ99mâïŒNâ²âãã¹ïŒã¡ã«ã«ããã¢ã»ã
ã«ïŒâïŒïŒïŒâãžã¢ãããããããšãŒãïŒTcâ
99mâCO2âDADSïŒã§ãã€ããéœåã®æªãããš
ã«ããã®ãªã¬ã³ãã¯ãã¬ãŒãåã®éã«ïŒã€ã®ç«äœ
ç°æ§äœçæç©ïŒTcâ99mâCO2âDADSâãã
ã³Tcâ99mâCO2âDADSâãšåŒã¶ïŒãšããŠå
åšãããããã«ãTcâ99mâCO2âDADSâç°
æ§äœã¯Tcâ99mâCO2âDADSâç°æ§äœããã
è èã§ã®åžåãã¯ããã«äœãããšãèŠåºãããã
ãããã®ïŒã€ã®ç°æ§äœãèšåºäžã®äœ¿çšã®ããã«å
é¢ããããšã¯å°é£ã§ããã®ã§ãTcâ99mâCO2
âDADSâã®åæ¥çéçºã¯å®çšçã§ãªãããšã
ãã€ãã åè¿°ã®ããšãããããæ¯èŒçé«ãåžåçãæã
ãã€ïŒ©â131 OIHã®ä»£æ¿ç©ãšããŠäžé©åœã§ãã
ãããªä»ã®äžå©ãªæ§è³ªã瀺ããªãTcâ99måå
ç©ãæäŸããããªãã°ãããã¯è æ©èœã€ã¡ãŒãžã³
ã°ã®åéã«ãããŠç»æçãªé²æ©ã§ãããšèªããã§
ããããããã«ãTcâ99mã¯ãã®åæžæãçã
ããã«ãè æ©èœèšºææ³ãè¡ãçŽåã«ãã®çš®ã®Tc
â99mååç©ãç°¡åã«è£œé ããããšãã§ãããªã
ã°ããããŸãèããé²æ©ã§ããã ããããã®çš®ã®
Tcâ99mååç©ããã³æ¹æ³ãæ¬æ现æžã«é瀺ã
ããã€è«æ±ãããã çºæã解決ããããšããåé¡ç¹ æ¬çºæã¯æŸå°æ§æšèãšããŠTcâ99mãçµèŸŒã
ã æ°èŠæŸå°æ§ã€ã¡ãŒãžã³ã°è¬å€ã«é¢ãããç¹ã«ã
æ¬æ现æžã§é瀺ããæ°èŠã€ã¡ãŒãžã³ã°è¬å€ã¯æ¯èŒ
çé«ãè èåžåçãæããããæ ã«è æ©èœã€ã¡ãŒ
ãžã³ã°æ¹æ³ãå®æœããéã«æçšã§ãããæ¬çºæã®
æ°èŠTcâ99mååç©ã¯æ¬¡ã®äžè¬åŒïŒ ãåŒäžãã¯ïŒ³ãŸãã¯ïŒ®ã§ããïŒïŒ¹ã¯âã§ã
ããããã㯠ïŒããã§R1ã¯âãâCH3ãŸãã¯âCH2CH3ã§
ããïŒR2ã¯âãâCH2CO2HãâCH2CONH2ãâ
CH2CH2CO2HãâCH2CH2CONH2ãâCH3ãâ
CH2CH3ãŸãã¯âCH2OHã§ããïŒãããŠïŒºã¯â
ãâCO2HãâCONH2ãâSO3HãâSO2NH2ãŸã
ã¯âCONHCH2CO2Hã§ããïŒã§ããïŒãããŠ
Tcã¯Tcâ99mã§ãã ã§è¡šããããååç©ããã³ãã®æ°Žæº¶æ§å¡©ã§ãããš
æšéãããã åèšã®ãã®ã®ãã¡ã§ç®äžã®ãšãã奜é©ãªæ¬çºæ
ã®Tcâ99mååç©ã¯Tcâ99mâã¡ã«ã«ããã¢ã»
ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ïŒTcâ99mâ
MAGGGïŒã§ããããã®ä»ã®å¥œé©ååç©ã¯Tcâ
99mâMAGGâã¢ã©ãã³ãTcâ99mâMAGGâ
ã°ã«ã¿ãã³ãããã³Tcâ99mâMAGGâã¢ã¹ã
ã©ã®ã³ã§ããã æ¬çºæã¯ãŸãTcâ99mãšåå¿ããŠåèšååç©
ã圢æãããæ°èŠãã¬ãŒãåå€ã«é¢ããããã®çš®
ã®æ°èŠãã¬ãŒãåå€ã¯æ¬¡ã®äžè¬åŒïŒ ïŒåŒäžãããã³ïŒ¹ã¯å ã«å®çŸ©ããéãã§ã
ãïŒïŒžãã§ãããšãYâ²ã¯âH2ã§ããããŸã
ãã§ãããšãYâ²ã¯âãâCOCH3ãâCOC6H5ã
âCH2NHCOCH3ãâCOCF3ãâCOCH2OHãâ
COCH2CO2ãŸãã¯ãã®ä»ã®é©åœãªä¿è·åºã§ããïŒ
ã§è¡šããããã æ¬çºæã¯æ°èŠTcâ99mååç©ã®è£œé æ¹æ³ãã
ã³äœ¿çšæ¹æ³ãæäŸããã åŸã€ãŠãæ¬çºæã®äž»ãªç®çã¯ã·ã³ãã°ã©ãæ³ã«
ãããŠæçšãªæ°èŠTcâ99mååç©ãæäŸããã
ãšã§ããã æ¬çºæã®ä»ã®ç®çã¯ãè èã«ãã€ãŠè¿ éãã€å¹
çããåžåãããããã«ãè æ©èœã€ã¡ãŒãžã³ã°ã®
åéã«ãããŠæçšã§ãããšããã®æ°èŠTcâ99m
ååç©ãæäŸããããšã§ããã æ¬çºæã®ããã«ä»ã®ç®çã¯ãTcâ99mååç©
ãã€ã¡ãŒãžã³ã°è¬å€ãšããŠäœ¿çšããçŽåã«ãã®å
åç©ã補é ããããã®æ¹æ³ãæäŸããããšã§ã
ãã æ¬çºæã®ãããã®ååç©ããã³ç¹åŸŽãªãã³ã«ä»
ã®ååç©ããã³ç¹åŸŽã¯ãæ·»ä»ã®ç¹èš±è«æ±ã®ç¯å²ã
ãã³ä»¥äžã®èª¬æããããã«æããã«ãªãã§ãã
ãã åé¡ã解決ããããã®æ段 æ¬çºæã¯è èã®å°¿çŽ°ç®¡ã®äžãžèœåçã«åæ³ã
ããããæ æŸå°èœå°¿è·¯é 圱æ³ã®ãããªè æ©èœè©Šéš
ã«äœ¿çšãããæ°èŠTcâ99mååç©ã«é¢ããã ãã詳现ã«ã¯ãæ¬çºæã¯Tcâ99mâã¡ã«ã«ã
ãã¢ã»ãã«âããªã¢ããé žååç©ïŒN3Sç³»ïŒãç¹
ã«æ¬¡ã®äžè¬åŒïŒ ãåŒäžãã¯âã§ããããããã㯠ïŒããã§R1ã¯âãâCH3ãŸãã¯âCH2CH3ã§
ããïŒR2ã¯âãâCH2CO2HãâCH2CONH2ãâ
CH2CH2CO2HãâCH2CH2CONH2ãâCH3ãâ
CH2CH3ãŸãã¯âCH2OHã§ããïŒãããŠïŒºã¯â
ãâCO2HãâCONH2ãâSO3HãâSO2NH2ãŸã
ã¯âCONHCH2CO2Hã§ããïŒã§ãããã§è¡šãã
ããTcâ99mâã¡ã«ã«ããã¢ã»ãã«ã°ãªã·ã«ã°
ãªã·ã«âã¢ããé žååç©ã«é¢ããã ãŸããæ¬çºæã¯äžèšã®äžè¬åŒã«é¡äŒŒããTcâ
99mååç©ãå å«ãããã ããã®ååç©ã¯æ¬¡åŒïŒ ïŒåŒäžãã¯å ã«å®çŸ©ããéãã§ããïŒã§è¡šã
ãããããã«ç¡«é»ãçªçŽ ã§çœ®æãããŠããã åè¿°ã®ãã®ã«å ããŠãæ¬çºæã¯æ¬¡ã®äžè¬åŒïŒ ïŒåŒäžãã¯ïŒ³ãŸãã¯ïŒ®ã§ããïŒïŒ¹ã¯å ã«å®çŸ©
ããéãã§ããïŒãããŠïœãïœã¯ããããïŒåã®
æ°ŽçŽ ååãŸãã¯äºéçµåã§çµåããé žçŽ ååãè¡š
ããïŒãã ããã§ããå Žåãïœã¯ïŒåã®æ°ŽçŽ
ååã§ãããïœãïœã®ãã¡å°ãªããšãïŒã€ã¯äºé
çµåã§çµããé žçŽ ååã§ããããããŠæ®ãã¯ïŒå
ã®æ°ŽçŽ ååã§ããïŒãŸããã§ããå Žåãïœã
ïœã®ãã¡å°ãªããšãïŒã€ã¯äºéçµåã§çµåããé ž
çŽ ååã§ããããããŠæ®ãã¯ïŒåã®æ°ŽçŽ ååã§ã
ãïŒã§è¡šããããTcâ99mååç©ãæäŸããã å ã«ç€ºããååç©ã«å ããŠæ¬çºæã¯ãããã®æ°Ž
溶æ§å¡©ãå å«ããã ããã«æ¬çºæã¯Tcâ99mãšåå¿ããŠåèšåå
ç©ã圢æãããæ°èŠãã¬ãŒãåå€ã«é¢ããããã®
çš®ã®æ°èŠãã¬ãŒãåå€ã¯æ¬¡ã®äžè¬åŒïŒ ãåŒäžãããã³ïŒ¹ã¯å ã«å®çŸ©ããéãã§ã
ãïŒïŒžãã§ãããšãYâ²ã¯âH2ã§ããããŸã
ãã§ãããšãYâ²ã¯âãâCOCH3ãâCOC6H5ã
âCH2NHCOCH3ãâCOCF3ãâCOCH2OHãâ
COCH2CO2HããŸãã¯ãã®ä»ã®é©åœãªä¿è·åºã§
ããïŒã§è¡šããããããã§ãã€ãŠYâ²ãâ
以å€ã®åèšåºã®ãã¡ã®ïŒã§ãããšããYâ²ã®äœ¿çš
ã¯ç¡«é»ãé žåããä¿è·ããã®ã«åœ¹ç«ã€ããã§
ããå Žåã«ã¯ãã®çš®ã®ä¿è·ãå¿ èŠãšããªãã æ¬çºæã®æ°èŠTcâ99mååç©ã®å¥œé©ãªåææ¹
æ³ã以äžã®åå¿åŒïŒããã§ã¯ç¹ã«Tcâ99mâã¡
ã«ã«ããã¢ã»ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³
ïŒTcâ99mâMAGGGïŒã®åææ¹æ³ã瀺ãïŒã§èª¬
æããã äžèšåå¿åŒã§ã¯ãã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³
ïŒååç©ïŒãå¡©åã¯ãã«ã¢ã»ãã«ãšåå¿ãããŠ
ã¯ãã«ã¢ã»ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ïŒåå
ç©ïŒè£œé ããã次ã«ååç©ãããªå®æ¯éŠé žã
ããªãŠã ãšåå¿ãããŠãã³ãŸã€ã«ã¡ã«ã«ããã¢ã»
ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ïŒååç©ïŒãç
æãããæåŸã«ååç©ãé©åœãªéå å€ã®ååšäž
ã«éãã¯ãããŠã é žãããªãŠã ãšåå¿ãããŠTc
â99mâMAGGGïŒååç©ïŒã補é ãããäžèš
ãšåãåæçµè·¯ã䜿çšããã€å¥ã®åºçºãªã¬ã³ãã
çšããããšã«ããæ¬çºæã®ç¯å²å ã®ä»ã®Tcâ
99mååç©ã補é ãåŸãããšãç解ãããã§ãã
ãã æ¬çºæã®æ°èŠTcâ99mååç©ã¯ããããæ£è
ã«éèå 泚å°ã§æäžããç¶ããŠã¬ã³ãã·ã³ãã¬ãŒ
ã·ãšã³ã«ã¡ã©ã䜿ã€ãŠæ£è ã®è èã®æ åãèšé²ã
ãããšã«ãã€ãŠãã·ã³ãã°ã©ãã€ãŒå°¿è·¯é 圱æ³ã«
ãããŠäœ¿çšããããå ã«è¿°ã¹ãããã«ã30000ã
ã€ã¯ãããŠãªãŒçšåºŠã®çšéã§Tcâ99mãæäžã
ãããšãå¯èœã§ããããã®ãããªé«çšéã®å Žåã¯
çãæŽè·¯æéãå¯èœã§ããã®ã§ããã¯è æ©èœã®å
çè©Šéšãè¡ãéã«æ¥µããŠæå©ã§ããã æ¬çºæã®æ°èŠTcâ99mååç©ã¯è èã®å°¿çŽ°ç®¡
ãžèœåçã«åæ³ãããŠèããé«ãåžåçã瀺ãã
ããæ â131 OIHã®ä»£æ¿ç©ãšããŠåœ¹ç«ã¡åŸã
ããšãèŠåºããããããã«ãäžèšã®æ§é åŒããæ
ããªããã«æ¬ååç©ã¯ç«äœç°æ§äœãšããŠååšããª
ãã®ã§ããã容æã«å®çšã«äŸãããã ããïŒãã
ããåºã®éžæã«ãã€ãŠã¯ãžã¢ã¹ãã¬ãªããŒãå
åšãããïŒã åè¿°ã®ããšããTcâ99mã®åæžæã¯çŽïŒæé
ã«ãããªãããã®çãåæžæã®ããã«ãTcâ
99mâãã¬ãŒããèšåºäžã®äœ¿çšã«åããŠå è£ ãã
ããšã¯å®éçã§ãªããæ¬çºæã®éèŠãªç¹åŸŽã¯ãæŸ
å°æ§å»è¬åãšããŠäœ¿çšããçŽåã«Tcâ99mâã
ã¬ãŒãã容æã«è£œé ããããããã®åœ¢ã§è©Šè¬é¡ã
å è£ ã§ããããšã§ããã åŸã€ãŠãå®éšå®€ã§ã¯ã¡ã«ã«ããã¢ã»ãã«ã°ãªã·
ã«ã°ãªã·ã«ã°ãªã·ã³ãšTcâ99méãã¯ãããŠã
é žå¡©ãšãäºäºããªã³é žå¡©éå å€ã®ååšäžã«åå¿ã
ããããšãå®éçã§ããããTcâ99mããã³äº
äºããªé žå¡©ã¯åæ¹ãšãäœããããã§ããæ°ãã補
é ããªããã°ãªããªãã ããäžå±€äŸ¿å©ãªåææ³ãçºèŠããããã®æ¹æ³ã¯
ã¢ã»ããŒããã¿ã«ãã¬ãŒãããã¬ãšãŒããã©ã¯ã
ãŒããããããã·ã€ãœããã¬ãŒããã·ãã¬ãŒãã
ã°ã«ã³ãããããŒãããã°ã«ã³ããŒãããããã¹
ããšãŒããâã¡ãã«ïŒ®ïŒNâ²âãã¹ïŒïŒâãã
ããã·ãšãã«ïŒãšãã¬ã³ãžã¢ãã³ãŸãã¯ã°ãªã·ã³
ã®ãããªé©åœãªäº€æãªã¬ã³ãäžéäœãšé¯åãã第
äžé«ã€ãªã³ã䜿çšããããã®ç¬¬äžé«ã€ãªã³ã¯äžèš
åå¿åŒã®ååç©ã®ãããªãªã¬ã³ããšéãã¯ãã
ãŠã é žãããªãŠã ãšã®åå¿ãèªçºããŠãååç©
ã®ãããªTcâ99mååç©ãçæãåŸãããšãã
ãã€ãã 第äžé«ã€ãªã³ã¯äºäºããªã³é žå¡©ã®ããã«æº¶æ¶²äž
ã§äžå®å®ã§ãªããåŸã€ãŠã第äžé«ã€ãªã³ã䜿çšã
ãæ¹æ³ã¯ãäžæ¹ã®ãã€ã¢ã«äžã®ç¬¬äžé«ã€ãªã³ïŒã
ãã³äº€æãªã¬ã³ãäžéäœïŒãšTcâ99mãžçµåã
ããã¹ããªã¬ã³ãïŒé·æä¿åãå¯èœã§ããïŒããª
ãã³ã«ä»æ¹ã®ãã€ã¢ã«äžã®éãã¯ãããŠã é žãã
ãªãŠã ã®ïŒã€ã®éšåããæããããã®åœ¢ã§å®¹æã«
å è£ å¯èœã§ãããäžè¬ã«ãéãã¯ãããŠã é žãã
ãªãŠã ã¯Tcâ99mã®åæžæãçãããã«å ¥æã
ãããMoâ99ïŒTcâ99mçºçå€ãããã®å Žã§è£œ
é ãããã ããã ïŒãïŒã®ä»£è¡šçãªå®æœäŸã¯æ¬çºæã®ç解ã«åœ¹ç«
ã€ã ãããå®æœäŸïŒããã³ïŒã¯ããããã¡ã«ã«ã
ãã¢ã»ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ããã³Tc
â99mâMAGGGã®å¥œé©ãªåææ¹æ³ã瀺ãã å®æœäŸ ïŒ ãã³ãŸã€ã«ã¡ã«ã«ããã¢ã»ãã«ã°ãªã·ã«ã°ãªã·
ã«ã°ãªã·ã³ã®åæ ãã³ãŸã€ã«ã¡ã«ã«ããã¢ã»ãã«ã°ãªã·ã«ã°ãªã·
ã«ã°ãªã·ã³ã®åæã¯ã500mlãã©ã¹ã³å ã®1.0Næ°Ž
é žåãããªãŠã 75mlã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³
2.5ïœãçªçŽ é°å²æ°äžïŒâã§æº¶è§£ããããšã«ãã
å€æ®µæ¹æ³ã§éå§ããã 次ã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³æº¶æ¶²ãé£ç¶æªæ
ããªããããã®æº¶æ¶²ã«ãšãŒãã«100mläžå¡©åã¯ã
ã«ã¢ã»ãã«13.0ïœå«æ溶液ã第ïŒã®æ·»å æŒæãã
滎äžããåæã«1.0Næ°Žé žåãããªãŠã 100mlã第
ïŒã®æ·»å æŒæãã滎äžãããå¡©åã¯ãã«ã¢ã»ãã«
ãšæ°Žé žåãããªãŠã ã®æ»Žäžå®äºåŸããã®åå¿æ··å
ç©ãïŒâã«ä¿ã€ãŠããã«1.5æéæªæããã ãã®åŸæ¿å¡©é žãå ããããšã«ããåå¿æ··åç©ã
çŽããšé žæ§åãããããã«30åæªæåŸãåå¿æ··å
ç©ã40âã«æããŠ1/3ã®å®¹éã«ãªããŸã§æžå§äžã«
æ¿çž®ããã ãã®æ¿çž®æ··åç©ã¯æ¬¡ãã§æ°·æµŽäžã§å·åŽããŠã¯ã
ã«ã¢ã»ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ãæåºãã
ããæ°Žã§ïŒåæŽæµåŸãã¯ãã«ã¢ã»ãã«ã°ãªã·ã«ã°
ãªã·ã«ã°ãªã·ã³2.75ïœïŒåºçºæ··åç©äžã«æº¶è§£ãã
ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ã®éã«åºã¥ããŠåç
78.5ïŒ ïŒãåŸãã 次ã«ãçªçŽ é°å²æ°äžã§ç²ã¯ãã«ã¢ã»ãã«ã°ãªã·
ã«ã°ãªã·ã«ã°ãªã·ã³ïŒïœãç¡æ°Žã¡ã¿ããŒã«300ml
ã«æº¶è§£ããããã®ãã©ã¹ã³ã«ããªå®æ¯éŠé žãããª
ãŠã å«æ溶液ïŒã¡ã¿ããŒã«äžã®ãããªãŠã 175mg
ã«ããªå®æ¯éŠé ž1.1ïœãæ·»å ããŠèª¿è£œãããã®ïŒ
50mlãå ãããã®åå¿æ··åç©ã1.5æééæµããã ãã®åŸæº¶åªãæžå§äžã«é€å»ãããåŸãããåºäœ
ãéã«ããåé¢ããã¯ãããã«ã ã§æŽã€ããã¡
ã¿ããŒã«ããçµæ¶åãããŠãã³ãŸã€ã«ã¡ã«ã«ãã
ã¢ã»ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³1.25ïœïŒ90
ïŒ ïŒãååããã ã¡ã¿ããŒã«ããã®çµæ¶åã§åŸãããçæç©ãã
ã³ãŸã€ã«ã¡ã«ã«ããã¢ã»ãã«ã°ãªã·ã«ã°ãªã·ã«ã°
ãªã·ã³ã§ããããšã蚌æããããã«å çŽ åæãè¡
ã€ãããã³ãŸã€ã«ã¡ã«ã«ããã¢ã»ãã«ã°ãªã·ã«ã°
ãªã·ã«ã°ãªã·ã³ãæ§æããççŽ ãæ°ŽçŽ ãçªçŽ ãã
ã³ç¡«é»ã®èšç®ããçè«å€ïŒïŒ ïŒã¯ãããã56.56ã
4.92ã5.74ããã³13.11ã§ãããå çŽ åæã®çµæã¯
ãããã6.50ã5.06ã5.67ããã³13.27ã§ãã€ãã
çè«å€ãšå®æž¬å€ãšãå®è³ªçäžèŽããããšã«ããã
ãã®åå¿é åºã®çæç©ããã³ãŸã€ã«ã¡ã«ã«ããã¢
ã»ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ã§ãããšå€æã
ãã å®æœäŸ ïŒ Tcâ99mã¡ã«ã«ããã¢ã»ãã«ã°ãªã·ã«ã°ãªã·
ã«ã°ãªã·ã³ã®åæ å ã«è¿°ã¹ãããã«ãæ¬çºæã®ïŒã€ã®éèŠãªç¹åŸŽ
ã¯æå³ããã€ã¡ãŒãžã³ã°è¬å€ã®åé§äœããããã®
圢ã§å è£ ã§ããããšã§ããããã®å®æœäŸã¯ã€ã¡ãŒ
ãžã³ã°è¬å€ãšããŠã®Tcâ99mâMAGGGã«é¢ä¿
ãããã®çš®ã®ãããã®è£œé ã«ã€ããŠç€ºãã äŸãã°ãçŽ100åã®ããããäœãå Žåã«ã¯ã
1.25M亀æãªã¬ã³ãäžéäœïŒã¢ã»ããŒããã°ãªã·
ã³ãã·ãã¬ãŒããããããŒããã°ã«ã³ããŒããã°
ã«ã³ãããããŒããããã¹ããšãŒããã¿ã«ãã¬ãŒ
ãããã¬ãšãŒããã©ã¯ããŒããããããã·ã€ãœã
ãã¬ãŒãããŸãã¯ïŒ®âã¡ãã«ïŒ®ïŒNâ²âãã¹ïŒïŒ
âããããã·ãšãã«ïŒãšãã¬ã³ãžã¢ãã³ãªã©ïŒ80
mlãçŽPH5.5ã«èª¿ç¯ãã次ã«çªçŽ ã¬ã¹ãæ£åžãã
ããšã«ãã€ãŠè±é µçŽ ããããã®åŸãã³ãŸã€ã«ã¡ã«
ã«ããã¢ã»ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³100mg
ãå ããéæ溶液ãåŸããããŸã§æªæããã 次ã«ã0.1Nå¡©é žïŒmläžã®SnCl2ã»2H2Oã®æ°ã
ã調補ãã10mgïŒml溶液0.2mlããã®æ··åç©ã«çª
çŽ é°å²æ°äžã§å ãããæåŸã«ãåŸãããæ··åç©ã¯
0.1N HClãŸãã¯NaOHã®é©éãå ããããšã«ã
ã€ãŠçŽPHïŒã«èª¿ç¯ããå šå®¹éã100mlãšãããã
ã«åžéãããããŠçªçŽ é°å²æ°ãä¿ã¡ãªãã0.2ã
ã¯ãã³ã®ãã€ã«ã¿ãŒãééãããŠæ» èããã10ml
ã®ã¢ãªã³ãŒããç¡èæè¡ãçšããŠãã€ã¢ã«ã«åé
ããåã ã®ã¢ãªã³ãŒãã¯ä¿åã®ããã«åçµãŸãã¯
åçµä¹Ÿç¥ãããå Žåã«ãã€ãŠã¯ã第äžé«ã€ãªã³å®
å®å€ïŒã²ã³ãã·ã³é žãŸãã¯ã¢ã¹ã³ã«ãã³é žãªã©ïŒ
ãå ããŠãããã Moâ99ïŒTcâ99mçºçå€ããææã¬ãã«ã®æŸ
å°èœãæããå¡©æ°Žäžã®Tcâ99méãã¯ãããŠã
é žå¡©çŽïŒãïŒmlãçæããåè¿°ã®ããã«ããŠèª¿è£œ
ããåå¿å€ãå«ããã€ã¢ã«ã®ïŒã€ã«æ·»å ãããæ··
å液ãTcâ99mâMAGGGãçæãããããã«
ãã®ãã€ã¢ã«ã沞隰氎济äžã«ïŒåéå ¥ããããã®
調補ç©ãå·åŽãããã以äžã®åŠçãè¡ãããšãªã
䜿çšããã å®æœäŸ ïŒ åææ¹æ³ ææãªãã°ãTcâ99mâMAGGGã®æ¥åžžåæ
ãããã·ã¬ã³å·ã¢ã³ã¢ãŒããŒã®ã²ã«ãã³ç€Ÿ
ïŒGelmanïŒInc.ïŒããå ¥æã§ãããããªITLCâ
SGã·ãªã«ã²ã«å«æµžã¬ã©ã¹ãã¢ã€ããŒã¹ããªãã
ã§ã®èå±€ã¯ãããã°ã©ãã€ãŒãçšããŠæå©ã«è¡ã
ããã å¯æº¶æ§ã®éçµåTcâ99méãã¯ãããŠã é žå¡©
ã®éã¯ãã¡ãã«ãšãã«ã±ãã³ã§å±éããã¹ããªã
ãã®æº¶åªå 端ã®æŸå°èœã枬å®ããããšã«ããåŸã
ãããäžæº¶æ§Tcâ99mã®éã¯ãå¡©æ°Žã§å±éãã
ã¹ããªããã®åç¹ç»åããæŸå°èœã枬å®ããããš
ã«ããåŸããããçµåTcâ99mã®çŸåçã¯æ¬¡ã®
åŒïŒ ïŒ çµåïŒ100âïŒ éçµåâïŒ äžæº¶æ§ ã«åŸã€ãŠèšç®ããã ãã¬ãŒãåTcâ99mâMAGGGçæç©ã®åæ
ã¯ãïŒãã¯ãã³ã®ODSã«ã©ã ãšå ±ã«ïŒïŒ ãšã¿ã
ãŒã«ïŒ95ïŒ 0.01Mçé žå¡©ïŒPHïŒïŒãããªã溶åªç³»
ã䜿çšããé«æ§èœæ¶²äœã¯ãããã°ã©ãã€ãŒ
ïŒHPLCïŒãçšããŠè¡ãããšãã§ãããTcâ99m
âMAGGGã¯1.0mlïŒåã®æµéã®å ŽåçŽïŒåã§äž»
èŠããŒã¯ãšãªãã芳å¯ãããä»ã®æåã¯çŽ2.5å
ã§ã®Tcâ99méãã¯ãããŠã é žå¡©ã§ããã å®æœäŸ ïŒ æ£åžžããŠã¹ã«ãããTcâ99mâMAGGGã®è
èã«ããå蟌㿠ïŒçŸ€ïŒå¹ã®ããŠã¹ïŒçŸ€ã«Tcâ99mâMAGGG
ãšïŒ©â131 OIHïŒæšæºå¯Ÿç §ïŒãšãåæã«æäžã
ããåããŠã¹ã«ã¯0.5ãã€ã¯ãããŠãªãŒã®Tcâ
99mâMAGGGããã³0.2ãã€ã¯ãããŠãªãŒã®ïŒ©
â131 OIHãå«æãã調補ç©0.1mlãéèå 泚å°
ãããã®åŸææ³ãããå°¿ãååã§ãã代è¬ã²ãŒãž
ã®äžã«å ¥ããã 泚å°ã®10ååŸã«åããŠã¹ã®å°¿éãçµã³ããããŠ
ã¯ãããã«ã èžæ°ã«ãã€ãŠããŠã¹ã殺ããã次
ã«ãæŸå°èœæšèããç©è³ªã®çç©ååžã調ã¹ããã
ã«çš®ã ã®ãµã³ãã«ãæ¡åããããããã®ãµã³ãã«
ã®çµæãè¡šã«ç€ºãã泚å°ã®120ååŸã«ç¬¬ïŒçŸ€ã®
ããŠã¹ã«å¯ŸããŠåæ§ã®æž¬å®ãè¡ãããã®çµæãè¡š
ã«ç€ºãã
è æ©èœã調ã¹ãåéã«ãããŠäœ¿çšããæ¹æ³ããã³
ååç©ã«é¢ããããã詳现ã«ã¯ãæ¬çºæã¯ãã¯ã
ããŠã â99mã§æŸå°èœæšèãããã¬ãŒãé¡ã䜿çš
ããããšã«ããè èç³»ã®ã€ã¡ãŒãžã³ã°ïŒæ å圢
æïŒã«é¢ããã åŸæ¥ã®æè¡ äººäœã®æ©èœã«é¢ããåºç€ççåŠã«ãããŠã¯äœæ¶²
ã®æåããã³éã®èª¿ç¯ãéåžžã«éèŠã§ãããäŸã
ã°ã人äœã§ã¯å šäœæ¶²éã现èå€äœæ¶²ã®æåãäœæ¶²
äžã®é žâå¡©åºãã©ã³ã¹ãããã³çŽ°èå€äœæ¶²ãšçŽ°è
å äœæ¶²ã®äº€æã«åœ±é¿ãåãŒãåçš®ã®å åïŒæãé¡
èã«ã¯ããã®ãããªäœæ¶²éã®æµžéé¢ä¿ã«åœ±é¿ãäž
ããå åïŒãªã©ã®äœæ¶²ã«é¢ããå€åã調ç¯ããã
ãšãå¿ èŠã§ããã è èã¯äœæ¶²ã®çµæã®èª¿ç¯ãã€ããã©ãéèŠãªè
åšã§ãããåŸã€ãŠãè èã¯æçµä»£è¬ç£ç©ã®å€§éšå
ãææ³ããã€æãŸããäœæ¶²æåã®æ¿åºŠã調ç¯ãã
ããšã«ãã€ãŠççåŠçã«èš±å®¹ãããç¯å²å ã«äœæ¶²
ãç¶æããã 人äœã¯èè±ãéã€ãŠææ³ãããäœæ¶²æåãå«ã
å°¿ãçæããããã®ïŒåã®è èãæããŠãããè
èã®åããè¡ãçç©åŠçãªåºæ¬åäœãâããã
ã³âã§ãããè èã¯ããããçŽ100äžã®ãããã³
ã§æ§æãããåãããã³ã¯ä»ã®ãããã³ãšã¯ç¡é¢
ä¿ã«äœæ¶²ã調ç¯ããããšãã§ããã è èã¯å®è³ªç容éã®è¡æ¶²ïŒå šæåºéã®çŽ1/5ã
çŽæ¥è èãžéãããïŒãéããããšã«ããäœæ¶²
ã«å¯ŸããŠæ©èœãããã®ç¹å®å®¹éã®è¡æ¶²ã¯âè èç»
åïŒrenal fractionïŒâãšããŠç¥ãããŠãããè¡
液ã¯äžè¬æ人ç·åã®è èãžå¹³åçŽ1.2ïŒåã®æµ
éã§æµãããè¡æ¶²ãè èãééãããšããããã
ã³ã¯äžèŠç©è³ªãäŸãã°æçµä»£è¬ç£ç©ïŒå°¿çŽ ãã¯ã¬
ã¢ããã³ãå°¿é žãç¡«é žå¡©ããã³ããšããŒã«ãªã©ïŒ
ããã³ã€ãªã³æ§é代è¬ç©è³ªïŒéå°ã®ãããªãŠã ã
ã«ãªãŠã ããã³å¡©çŽ ã€ãªã³ãªã©ïŒãè¡æŒ¿ããåã
é€ãã ãããã³ã¯åºæ¬çã«â糞çäœâãšåŒã°ããæ¯çŽ°
è¡ç®¡åºãâ管åšâæ¯çŽ°è¡ç®¡ïŒperitubular
capillaryïŒãšããŠç¥ããã第ïŒã®æ¯çŽ°è¡ç®¡åºã
ããã³â尿现管âãšããŠç¥ãããå°¿çæéšåãã
ãªã€ãŠããã尿现管ã¯â糞çäœèâãšããŠç¥ãã
ãèã«ãã€ãŠç³žçäœããåé¢ããããè¡æ¶²ã®è è
ç»åã糞çäœãééãããšãã糞çäœèã¯è èç»
åãããªãè¡æŒ¿ã®å°éå²åïŒäžè¬ã«ã¯20ã25ïŒ ä»¥
äžïŒã尿现管ãžéãããã®åŸãã®éäœæ¶²ã¯å°¿çŽ°
管ãéã€ãŠè èã®è ã®æ¹ãžæµãããããŠèè±ãžãš
é ã«éã°ãããäœæ¶²ã尿现管ãééãããšãã倧
éšåã®æ°Žã倧éšåã®é»è§£è³ªãããã³ãã®ä»ã®âå¿
èŠâç©è³ªã¯ååžåãããŠè¡æ¶²ãžæ»ããâäžèŠâç©
質ïŒæçµä»£è¬ç£ç©ãéå°ã®æ°Žããã³é»è§£è³ªãªã©ïŒ
ãå°¿ãšããŠææ³ãããããã«èè±ãžéãããã 糞çäœèãééããªãè èç»åã®æ®ãã®éšåã¯
ãã®ç³žçäœã«ãšã©ãŸãããã®åŸç®¡åšæ¯çŽ°è¡ç®¡ãžå ¥
ããããããè èç»åã®äžéšãäžè¬ã«ã¯éèç³»ãž
æ»ãããã尿现管ã§ååžåããã倧éã®äœæ¶²ãå°¿
现管èãéã€ãŠæ¡æ£ã«ãã管åšæ¯çŽ°è¡ç®¡ãžéã°ã
ãã 倧éã®äœæ¶²ã¯å°¿çŽ°ç®¡ãã管åšæ¯çŽ°è¡ç®¡ãžæ¡æ£ã
ãŠè¡ç®¡ç³»ã«æ»ãããè¥å¹²ã®è¡æŒ¿ã¯éæ¹åãããªã
ã¡ç®¡åšæ¯çŽ°è¡ç®¡ãã尿现管ãžã®æ¡æ£ãããããäŸ
ãã°ã尿现管èãéã€ãŠç®¡åšäœæ¶²äžãžãããªãŠã
ã€ãªã³ãèœåçã«éã¶ããšã«ãããã®éèŠãªé»è§£
質ã倱ãããã«ããããäžæ¹ã§ãã®ããšã¯å°¿çŽ°ç®¡
å ã«ç®¡åšäœæ¶²ã«å¯Ÿããå®è³ªçé°é»è·ãçããã
ããè¿äœå°¿çŽ°ç®¡ã«ãããŠã¯ãã®é»äœå·®ãçŽ20ããª
ãã«ãã§ããããããŠé äœå°¿çŽ°ç®¡ã§ã¯ããã120
ããªãã«ãçšåºŠã«äžæãããã ãã®é»äœå·®ã¯ããçš®ã®éœã€ãªã³ïŒæãé¡èã«ã¯
ã«ãªãŠã ã€ãªã³ïŒã管åšäœæ¶²ãã尿现管ãžæ¡æ£ã
ãããé»æ°é°æ§åºŠåŸé ã«ãã尿现管èãçµã尿现
管ãžã®ã«ãªãŠã ã€ãªã³ã®ç§»åã¯âåååæ³
ïŒpassive secretionïŒâãšåŒã°ããã ãã®åååæ³ã«å ããŠãè¥å¹²ã®ã€ãªã³æ§ç©è³ªã¯
尿现管ã®äžãžâèœåçâã«åæ³ããããäŸãã°ã
ãã©âã¢ããéŠ¬å°¿é žïŒäžè¬ã«ã¯PAHãšåŒã¶ïŒã¯
管åšäœæ¶²ãã尿现管ãžèœåçã«åæ³ãããè èç»
åã®çŽ20ïŒ ã®ã¿ã糞çäœæ¶²ãšããŠå°¿çŽ°ç®¡ãžéã
ããã«ãããªããã®ã«ãããããããè¡æ¶²äžã®
PAHã¯ãã®90ïŒ è¿ããè èã«ãã€ãŠé€å»ãããã
åŸã€ãŠãPAHã®çŽ70ïŒ ã¯å°¿çŽ°ç®¡ãžã®èœååæ³ã«
ãã€ãŠè¡æŒ¿ããé€ãããããšã«ãªãã æãããè èãæå·ãåããŠããã®çµæè¡æ¶²æµ
åäœçšãäœäžããããããã¯ãã®æµåäœçšãåæ¢
ããããšããããã ãããçºçããè èã®æå·ã®
çšåºŠãšåãå»åž«ãè©äŸ¡ããã®ãå©ããããã«ãå
çš®ã®è æ©èœè©Šéšãèæ¡ãããããŸãããããã®è
æ©èœè©Šéšã¯è è移æ€æè¡åŸã«è èãé©åã«åããŠ
ãããã©ããã調ã¹ãã®ã«æçšã§ããã ãã®ãããªè æ©èœè©Šéšæ¹æ³ã®ïŒã€ã¯éèå ã·ã³
ãã°ã©ãã€ãŒå°¿è·¯é 圱æ³ãšããŠç¥ããããã®ã§ã
ãïŒãã®æ¹æ³ã¯ãŸãåçè æ©èœã€ã¡ãŒãžã³ã°æ³ãš
ããŠãæ®éã«ç¥ãããŠããïŒããã®æ¹æ³ã¯ããšã
ãšïŒ©â131ãªã«ãâãšãŒãéŠ¬å°¿é žå¡©ïŒïŒ©â
131OIHãšåŒã°ããïŒã®ãããªæŸå°èœæšèãããš
ãŠçŽ ç©è³ªã®éèå æäžããšããªããPAHãšåæ§
ã«ãâ131 OIHã¯ç³žçäœã§ã®éã«å ããŠå°¿
现管ãžã®èœååæ³ã«ãã€ãŠè¡æ¶²ããè¿ éã«é€ã
ãããã®çµææäžåŸïŒãïŒå以å ã«ææéã®æŸå°
èœæšèç©è³ªãè èå ã«æ¿çž®ãããããã®æŸå°èœæš
èç©è³ªã®äœçœ®ã瀺ãããšãã§ããã¬ã³ãã·ã³ãã¬
ãŒã·ãšã³ã«ã¡ã©ã䜿ã€ãŠæ åãåŸãããã«ããè
èã«ãããè æ©èœã®æ¬è³ªãç¥ãããšãã§ããã è æ©èœãè©äŸ¡ããéã«ïŒ©â131 OIHãéèŠãª
æ段ã§ãããšããäºå®ã«ãããããããããã«ã¯
ããã€ãã®æãããªé£ç¹ãååšããããŸã第äž
ã«ããšãŠçŽ â131ïŒïŒ©â131ïŒãé«ãšãã«ã®ãŒã¬ã³
ãæŸå°ç·éïŒ364KeVïŒãæããããã«ãâ
131 OIHã®äœ¿çšã¯ç©ºéçå解ã®ä¹ããæ åãã
ãããããã®ããšã¯è èå ã®çŽ°éšã®èŠ³å¯ãå°é£ã«
ãããã®çµæãã®æ¹æ³ã«ãã€ãŠåŸãããæçšãªæ
å ±éãå¶éãããã ããã«ãâ131 OIHã®è èåžåçïŒè èã
ééããè¡æ¶²ããæŸå°æ§è¬åãåãé€ãèœåïŒã
çŽ65ã80ïŒ ã§ããã«ããããããã¯ããªãããæ¹
ã§ã¯ããããããã«é«ãåžåçã¯ããã«é«ãè è
察åºåºå€ïŒããã¯ã°ã©ãŠã³ãïŒæ¯ããããããŠè
æ©èœã®æ€åºã容æã«ããã ããããŸããâ131
ã¯æŸå°æ§åŽ©å£äžã«ããŒã¿ç²åãæŸå°ããŠåšå²ã®çµ
ç¹ã«æå·ãäžããã ãããããã«ãâ131
OIHã«ä»éããéé¢ã®æŸå°æ§ãšãŠçŽ ã¯æ£è ã®ç²
ç¶è ºã«åžåãããããã®ã§ãâ131 OIHã®æ
倧ç·éãäžè¬ã«çŽ200ã300ãã€ã¯ãããŠãªãŒã«ç¶
æããªããã°ãªããªãããã®äœãæäžéã¯æŸå°æ§
ç»åãåŸãå Žåã«ããªãã®æŽé²æéãå¿ èŠãšãã
è æ©èœæ€æ»äžã«åŸãããé£ç¶ç»åã®æéçå解èœ
ãé 次æžå°ãããã æŸå°ç·ã«ããè æ©èœæž¬å®æ¹æ³ã«ãããŠåŸããã
å解èœãæ¹è¯ããããã«ãå¥ã®æŸå°èœæšèç©è³ªã
ç±å¿ã«æ¢ãæ±ããããŠãããä»æ¥ã§ã¯ãæãæãŸ
ããæŸå°æ§æšèããã¯ãããŠã â99mïŒTcâ
99mïŒã§ãããšèãããããã®Tcâ99mã¯ãã
äœããšãã«ã®ãŒïŒ140KeVïŒã®æŸå°ç·ãæŸå°ãã
ã®ã§ïŒ©â131æšèãšæ¯èŒããå Žåã«ããªãæ¹è¯ã
ããå解ç¹æ§ãæããŠããããã®æ¯èŒçäœããšã
ã«ã®ãŒã®æŸå°ç·ã¯æšæºçãªæŸå°ç·æž¬å®è£ 眮ãšå ±ã«
䜿çšããã®ã«ããé©åãããïŒããªããŠãªãŒåœã
ãã®æŸå°ç·éã¯ïŒ©â131ã䜿çšããå ŽåãããTc
â99mã®æ¹ãã¯ããã«å°ãªãããªããªãâ131
ã®åæžæãïŒæ¥ã§ããã®ã«å¯ŸããŠTcâ99mã®å
æžæã¯çŽïŒæéã§ããã«ãããããŸãTcâ99m
ã¯ãã®åŽ©å£éçšäžã«ããŒã¿ç²åãæŸå°ããªããã
ã§ããã Tcâ99mã®æŸå°èœç¹æ§ã¯æºå®å®æ§ã®å±èµ·ãã
ãååæ žãåºåºç¶æ ã®Tcâ99ãžé·ç§»ããããšã«
èµ·å ãããçããTcâ99ã¯å®è³ªçã«ç¡å®³ã§ãã
ã»ã©ã®é·ãåæžæïŒ200000幎ïŒãæããŠãããã
ã®çµæã30000ãã€ã¯ãããŠãªãŒçšåºŠã®Tcâ99m
ãæ£è ã«å±éºãäžããããšãªãæäžãåŸããåŸã€
ãŠïŒ©â131 OIHã䜿çšããå Žåãããããªãç
ãæŽé²æéã§ãã¿ãããã«ããæŸå°æ§è¬åãè è
ãæåã«ééããéã«èš±å®¹ã§ããæœ æµæ å
ïŒperfusion imageïŒãåŸãããšãã§ããã Tcâ99mã®äžèšç¹æ§ã¯ããããæšæºè£ 眮ãšå ±
ã«äœ¿çšããã®ã«ããé©åããã€ããã䜿çšããæ£
è ã«æ¯èŒçäœãæŸå°ç·éãäžããã®ã§ãæ žå»çã«
ãããïŒã€ã®æ段ãšããŠçæ³çã§ããã â131æšèãšæ¯ã¹ããšãã®Tcâ99mæšèã®äž
èšå©ç¹ããã«ãé«ãè èåžåçãæããTcâ
99mååç©ã®éçºã«å¯ŸããŠå€å€§ã®åªåãæãããŠ
ãããå€æ°ã®Tcâ99mã§æšèããããã¬ãŒãé¡
ãæç®äžã«å ±åãããŠããã Tcâ99mæšèååç©ã®ïŒã€ãšããŠTcâ99mãž
ãšãã¬ã³ããªã¢ãã³äºé ¢é žïŒäžè¬ã«Tcâ99mâ
DTPAãšåŒã¶ïŒãã³ãŸãã«ã«ããã·ã¬ãŒãããž
ã«ã«ããã·ã¬ãŒããããã³ãã³ãŸã«ã«ããã·ã¬ãŒ
ãé¡äŒŒäœãåæãããŠãã€è©Šéšãããã ãããã®ãã¡ã§æãå¹çããææ³ãããé¡äŒŒäœ
ã¯Tcâ99mâïŒNâ²âãã¹ïŒã¡ã«ã«ããã¢ã»ã
ã«ïŒâïŒïŒïŒâãžã¢ãããããããšãŒãïŒTcâ
99mâCO2âDADSïŒã§ãã€ããéœåã®æªãããš
ã«ããã®ãªã¬ã³ãã¯ãã¬ãŒãåã®éã«ïŒã€ã®ç«äœ
ç°æ§äœçæç©ïŒTcâ99mâCO2âDADSâãã
ã³Tcâ99mâCO2âDADSâãšåŒã¶ïŒãšããŠå
åšãããããã«ãTcâ99mâCO2âDADSâç°
æ§äœã¯Tcâ99mâCO2âDADSâç°æ§äœããã
è èã§ã®åžåãã¯ããã«äœãããšãèŠåºãããã
ãããã®ïŒã€ã®ç°æ§äœãèšåºäžã®äœ¿çšã®ããã«å
é¢ããããšã¯å°é£ã§ããã®ã§ãTcâ99mâCO2
âDADSâã®åæ¥çéçºã¯å®çšçã§ãªãããšã
ãã€ãã åè¿°ã®ããšãããããæ¯èŒçé«ãåžåçãæã
ãã€ïŒ©â131 OIHã®ä»£æ¿ç©ãšããŠäžé©åœã§ãã
ãããªä»ã®äžå©ãªæ§è³ªã瀺ããªãTcâ99måå
ç©ãæäŸããããªãã°ãããã¯è æ©èœã€ã¡ãŒãžã³
ã°ã®åéã«ãããŠç»æçãªé²æ©ã§ãããšèªããã§
ããããããã«ãTcâ99mã¯ãã®åæžæãçã
ããã«ãè æ©èœèšºææ³ãè¡ãçŽåã«ãã®çš®ã®Tc
â99mååç©ãç°¡åã«è£œé ããããšãã§ãããªã
ã°ããããŸãèããé²æ©ã§ããã ããããã®çš®ã®
Tcâ99mååç©ããã³æ¹æ³ãæ¬æ现æžã«é瀺ã
ããã€è«æ±ãããã çºæã解決ããããšããåé¡ç¹ æ¬çºæã¯æŸå°æ§æšèãšããŠTcâ99mãçµèŸŒã
ã æ°èŠæŸå°æ§ã€ã¡ãŒãžã³ã°è¬å€ã«é¢ãããç¹ã«ã
æ¬æ现æžã§é瀺ããæ°èŠã€ã¡ãŒãžã³ã°è¬å€ã¯æ¯èŒ
çé«ãè èåžåçãæããããæ ã«è æ©èœã€ã¡ãŒ
ãžã³ã°æ¹æ³ãå®æœããéã«æçšã§ãããæ¬çºæã®
æ°èŠTcâ99mååç©ã¯æ¬¡ã®äžè¬åŒïŒ ãåŒäžãã¯ïŒ³ãŸãã¯ïŒ®ã§ããïŒïŒ¹ã¯âã§ã
ããããã㯠ïŒããã§R1ã¯âãâCH3ãŸãã¯âCH2CH3ã§
ããïŒR2ã¯âãâCH2CO2HãâCH2CONH2ãâ
CH2CH2CO2HãâCH2CH2CONH2ãâCH3ãâ
CH2CH3ãŸãã¯âCH2OHã§ããïŒãããŠïŒºã¯â
ãâCO2HãâCONH2ãâSO3HãâSO2NH2ãŸã
ã¯âCONHCH2CO2Hã§ããïŒã§ããïŒãããŠ
Tcã¯Tcâ99mã§ãã ã§è¡šããããååç©ããã³ãã®æ°Žæº¶æ§å¡©ã§ãããš
æšéãããã åèšã®ãã®ã®ãã¡ã§ç®äžã®ãšãã奜é©ãªæ¬çºæ
ã®Tcâ99mååç©ã¯Tcâ99mâã¡ã«ã«ããã¢ã»
ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ïŒTcâ99mâ
MAGGGïŒã§ããããã®ä»ã®å¥œé©ååç©ã¯Tcâ
99mâMAGGâã¢ã©ãã³ãTcâ99mâMAGGâ
ã°ã«ã¿ãã³ãããã³Tcâ99mâMAGGâã¢ã¹ã
ã©ã®ã³ã§ããã æ¬çºæã¯ãŸãTcâ99mãšåå¿ããŠåèšååç©
ã圢æãããæ°èŠãã¬ãŒãåå€ã«é¢ããããã®çš®
ã®æ°èŠãã¬ãŒãåå€ã¯æ¬¡ã®äžè¬åŒïŒ ïŒåŒäžãããã³ïŒ¹ã¯å ã«å®çŸ©ããéãã§ã
ãïŒïŒžãã§ãããšãYâ²ã¯âH2ã§ããããŸã
ãã§ãããšãYâ²ã¯âãâCOCH3ãâCOC6H5ã
âCH2NHCOCH3ãâCOCF3ãâCOCH2OHãâ
COCH2CO2ãŸãã¯ãã®ä»ã®é©åœãªä¿è·åºã§ããïŒ
ã§è¡šããããã æ¬çºæã¯æ°èŠTcâ99mååç©ã®è£œé æ¹æ³ãã
ã³äœ¿çšæ¹æ³ãæäŸããã åŸã€ãŠãæ¬çºæã®äž»ãªç®çã¯ã·ã³ãã°ã©ãæ³ã«
ãããŠæçšãªæ°èŠTcâ99mååç©ãæäŸããã
ãšã§ããã æ¬çºæã®ä»ã®ç®çã¯ãè èã«ãã€ãŠè¿ éãã€å¹
çããåžåãããããã«ãè æ©èœã€ã¡ãŒãžã³ã°ã®
åéã«ãããŠæçšã§ãããšããã®æ°èŠTcâ99m
ååç©ãæäŸããããšã§ããã æ¬çºæã®ããã«ä»ã®ç®çã¯ãTcâ99mååç©
ãã€ã¡ãŒãžã³ã°è¬å€ãšããŠäœ¿çšããçŽåã«ãã®å
åç©ã補é ããããã®æ¹æ³ãæäŸããããšã§ã
ãã æ¬çºæã®ãããã®ååç©ããã³ç¹åŸŽãªãã³ã«ä»
ã®ååç©ããã³ç¹åŸŽã¯ãæ·»ä»ã®ç¹èš±è«æ±ã®ç¯å²ã
ãã³ä»¥äžã®èª¬æããããã«æããã«ãªãã§ãã
ãã åé¡ã解決ããããã®æ段 æ¬çºæã¯è èã®å°¿çŽ°ç®¡ã®äžãžèœåçã«åæ³ã
ããããæ æŸå°èœå°¿è·¯é 圱æ³ã®ãããªè æ©èœè©Šéš
ã«äœ¿çšãããæ°èŠTcâ99mååç©ã«é¢ããã ãã詳现ã«ã¯ãæ¬çºæã¯Tcâ99mâã¡ã«ã«ã
ãã¢ã»ãã«âããªã¢ããé žååç©ïŒN3Sç³»ïŒãç¹
ã«æ¬¡ã®äžè¬åŒïŒ ãåŒäžãã¯âã§ããããããã㯠ïŒããã§R1ã¯âãâCH3ãŸãã¯âCH2CH3ã§
ããïŒR2ã¯âãâCH2CO2HãâCH2CONH2ãâ
CH2CH2CO2HãâCH2CH2CONH2ãâCH3ãâ
CH2CH3ãŸãã¯âCH2OHã§ããïŒãããŠïŒºã¯â
ãâCO2HãâCONH2ãâSO3HãâSO2NH2ãŸã
ã¯âCONHCH2CO2Hã§ããïŒã§ãããã§è¡šãã
ããTcâ99mâã¡ã«ã«ããã¢ã»ãã«ã°ãªã·ã«ã°
ãªã·ã«âã¢ããé žååç©ã«é¢ããã ãŸããæ¬çºæã¯äžèšã®äžè¬åŒã«é¡äŒŒããTcâ
99mååç©ãå å«ãããã ããã®ååç©ã¯æ¬¡åŒïŒ ïŒåŒäžãã¯å ã«å®çŸ©ããéãã§ããïŒã§è¡šã
ãããããã«ç¡«é»ãçªçŽ ã§çœ®æãããŠããã åè¿°ã®ãã®ã«å ããŠãæ¬çºæã¯æ¬¡ã®äžè¬åŒïŒ ïŒåŒäžãã¯ïŒ³ãŸãã¯ïŒ®ã§ããïŒïŒ¹ã¯å ã«å®çŸ©
ããéãã§ããïŒãããŠïœãïœã¯ããããïŒåã®
æ°ŽçŽ ååãŸãã¯äºéçµåã§çµåããé žçŽ ååãè¡š
ããïŒãã ããã§ããå Žåãïœã¯ïŒåã®æ°ŽçŽ
ååã§ãããïœãïœã®ãã¡å°ãªããšãïŒã€ã¯äºé
çµåã§çµããé žçŽ ååã§ããããããŠæ®ãã¯ïŒå
ã®æ°ŽçŽ ååã§ããïŒãŸããã§ããå Žåãïœã
ïœã®ãã¡å°ãªããšãïŒã€ã¯äºéçµåã§çµåããé ž
çŽ ååã§ããããããŠæ®ãã¯ïŒåã®æ°ŽçŽ ååã§ã
ãïŒã§è¡šããããTcâ99mååç©ãæäŸããã å ã«ç€ºããååç©ã«å ããŠæ¬çºæã¯ãããã®æ°Ž
溶æ§å¡©ãå å«ããã ããã«æ¬çºæã¯Tcâ99mãšåå¿ããŠåèšåå
ç©ã圢æãããæ°èŠãã¬ãŒãåå€ã«é¢ããããã®
çš®ã®æ°èŠãã¬ãŒãåå€ã¯æ¬¡ã®äžè¬åŒïŒ ãåŒäžãããã³ïŒ¹ã¯å ã«å®çŸ©ããéãã§ã
ãïŒïŒžãã§ãããšãYâ²ã¯âH2ã§ããããŸã
ãã§ãããšãYâ²ã¯âãâCOCH3ãâCOC6H5ã
âCH2NHCOCH3ãâCOCF3ãâCOCH2OHãâ
COCH2CO2HããŸãã¯ãã®ä»ã®é©åœãªä¿è·åºã§
ããïŒã§è¡šããããããã§ãã€ãŠYâ²ãâ
以å€ã®åèšåºã®ãã¡ã®ïŒã§ãããšããYâ²ã®äœ¿çš
ã¯ç¡«é»ãé žåããä¿è·ããã®ã«åœ¹ç«ã€ããã§
ããå Žåã«ã¯ãã®çš®ã®ä¿è·ãå¿ èŠãšããªãã æ¬çºæã®æ°èŠTcâ99mååç©ã®å¥œé©ãªåææ¹
æ³ã以äžã®åå¿åŒïŒããã§ã¯ç¹ã«Tcâ99mâã¡
ã«ã«ããã¢ã»ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³
ïŒTcâ99mâMAGGGïŒã®åææ¹æ³ã瀺ãïŒã§èª¬
æããã äžèšåå¿åŒã§ã¯ãã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³
ïŒååç©ïŒãå¡©åã¯ãã«ã¢ã»ãã«ãšåå¿ãããŠ
ã¯ãã«ã¢ã»ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ïŒåå
ç©ïŒè£œé ããã次ã«ååç©ãããªå®æ¯éŠé žã
ããªãŠã ãšåå¿ãããŠãã³ãŸã€ã«ã¡ã«ã«ããã¢ã»
ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ïŒååç©ïŒãç
æãããæåŸã«ååç©ãé©åœãªéå å€ã®ååšäž
ã«éãã¯ãããŠã é žãããªãŠã ãšåå¿ãããŠTc
â99mâMAGGGïŒååç©ïŒã補é ãããäžèš
ãšåãåæçµè·¯ã䜿çšããã€å¥ã®åºçºãªã¬ã³ãã
çšããããšã«ããæ¬çºæã®ç¯å²å ã®ä»ã®Tcâ
99mååç©ã補é ãåŸãããšãç解ãããã§ãã
ãã æ¬çºæã®æ°èŠTcâ99mååç©ã¯ããããæ£è
ã«éèå 泚å°ã§æäžããç¶ããŠã¬ã³ãã·ã³ãã¬ãŒ
ã·ãšã³ã«ã¡ã©ã䜿ã€ãŠæ£è ã®è èã®æ åãèšé²ã
ãããšã«ãã€ãŠãã·ã³ãã°ã©ãã€ãŒå°¿è·¯é 圱æ³ã«
ãããŠäœ¿çšããããå ã«è¿°ã¹ãããã«ã30000ã
ã€ã¯ãããŠãªãŒçšåºŠã®çšéã§Tcâ99mãæäžã
ãããšãå¯èœã§ããããã®ãããªé«çšéã®å Žåã¯
çãæŽè·¯æéãå¯èœã§ããã®ã§ããã¯è æ©èœã®å
çè©Šéšãè¡ãéã«æ¥µããŠæå©ã§ããã æ¬çºæã®æ°èŠTcâ99mååç©ã¯è èã®å°¿çŽ°ç®¡
ãžèœåçã«åæ³ãããŠèããé«ãåžåçã瀺ãã
ããæ â131 OIHã®ä»£æ¿ç©ãšããŠåœ¹ç«ã¡åŸã
ããšãèŠåºããããããã«ãäžèšã®æ§é åŒããæ
ããªããã«æ¬ååç©ã¯ç«äœç°æ§äœãšããŠååšããª
ãã®ã§ããã容æã«å®çšã«äŸãããã ããïŒãã
ããåºã®éžæã«ãã€ãŠã¯ãžã¢ã¹ãã¬ãªããŒãå
åšãããïŒã åè¿°ã®ããšããTcâ99mã®åæžæã¯çŽïŒæé
ã«ãããªãããã®çãåæžæã®ããã«ãTcâ
99mâãã¬ãŒããèšåºäžã®äœ¿çšã«åããŠå è£ ãã
ããšã¯å®éçã§ãªããæ¬çºæã®éèŠãªç¹åŸŽã¯ãæŸ
å°æ§å»è¬åãšããŠäœ¿çšããçŽåã«Tcâ99mâã
ã¬ãŒãã容æã«è£œé ããããããã®åœ¢ã§è©Šè¬é¡ã
å è£ ã§ããããšã§ããã åŸã€ãŠãå®éšå®€ã§ã¯ã¡ã«ã«ããã¢ã»ãã«ã°ãªã·
ã«ã°ãªã·ã«ã°ãªã·ã³ãšTcâ99méãã¯ãããŠã
é žå¡©ãšãäºäºããªã³é žå¡©éå å€ã®ååšäžã«åå¿ã
ããããšãå®éçã§ããããTcâ99mããã³äº
äºããªé žå¡©ã¯åæ¹ãšãäœããããã§ããæ°ãã補
é ããªããã°ãªããªãã ããäžå±€äŸ¿å©ãªåææ³ãçºèŠããããã®æ¹æ³ã¯
ã¢ã»ããŒããã¿ã«ãã¬ãŒãããã¬ãšãŒããã©ã¯ã
ãŒããããããã·ã€ãœããã¬ãŒããã·ãã¬ãŒãã
ã°ã«ã³ãããããŒãããã°ã«ã³ããŒãããããã¹
ããšãŒããâã¡ãã«ïŒ®ïŒNâ²âãã¹ïŒïŒâãã
ããã·ãšãã«ïŒãšãã¬ã³ãžã¢ãã³ãŸãã¯ã°ãªã·ã³
ã®ãããªé©åœãªäº€æãªã¬ã³ãäžéäœãšé¯åãã第
äžé«ã€ãªã³ã䜿çšããããã®ç¬¬äžé«ã€ãªã³ã¯äžèš
åå¿åŒã®ååç©ã®ãããªãªã¬ã³ããšéãã¯ãã
ãŠã é žãããªãŠã ãšã®åå¿ãèªçºããŠãååç©
ã®ãããªTcâ99mååç©ãçæãåŸãããšãã
ãã€ãã 第äžé«ã€ãªã³ã¯äºäºããªã³é žå¡©ã®ããã«æº¶æ¶²äž
ã§äžå®å®ã§ãªããåŸã€ãŠã第äžé«ã€ãªã³ã䜿çšã
ãæ¹æ³ã¯ãäžæ¹ã®ãã€ã¢ã«äžã®ç¬¬äžé«ã€ãªã³ïŒã
ãã³äº€æãªã¬ã³ãäžéäœïŒãšTcâ99mãžçµåã
ããã¹ããªã¬ã³ãïŒé·æä¿åãå¯èœã§ããïŒããª
ãã³ã«ä»æ¹ã®ãã€ã¢ã«äžã®éãã¯ãããŠã é žãã
ãªãŠã ã®ïŒã€ã®éšåããæããããã®åœ¢ã§å®¹æã«
å è£ å¯èœã§ãããäžè¬ã«ãéãã¯ãããŠã é žãã
ãªãŠã ã¯Tcâ99mã®åæžæãçãããã«å ¥æã
ãããMoâ99ïŒTcâ99mçºçå€ãããã®å Žã§è£œ
é ãããã ããã ïŒãïŒã®ä»£è¡šçãªå®æœäŸã¯æ¬çºæã®ç解ã«åœ¹ç«
ã€ã ãããå®æœäŸïŒããã³ïŒã¯ããããã¡ã«ã«ã
ãã¢ã»ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ããã³Tc
â99mâMAGGGã®å¥œé©ãªåææ¹æ³ã瀺ãã å®æœäŸ ïŒ ãã³ãŸã€ã«ã¡ã«ã«ããã¢ã»ãã«ã°ãªã·ã«ã°ãªã·
ã«ã°ãªã·ã³ã®åæ ãã³ãŸã€ã«ã¡ã«ã«ããã¢ã»ãã«ã°ãªã·ã«ã°ãªã·
ã«ã°ãªã·ã³ã®åæã¯ã500mlãã©ã¹ã³å ã®1.0Næ°Ž
é žåãããªãŠã 75mlã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³
2.5ïœãçªçŽ é°å²æ°äžïŒâã§æº¶è§£ããããšã«ãã
å€æ®µæ¹æ³ã§éå§ããã 次ã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³æº¶æ¶²ãé£ç¶æªæ
ããªããããã®æº¶æ¶²ã«ãšãŒãã«100mläžå¡©åã¯ã
ã«ã¢ã»ãã«13.0ïœå«æ溶液ã第ïŒã®æ·»å æŒæãã
滎äžããåæã«1.0Næ°Žé žåãããªãŠã 100mlã第
ïŒã®æ·»å æŒæãã滎äžãããå¡©åã¯ãã«ã¢ã»ãã«
ãšæ°Žé žåãããªãŠã ã®æ»Žäžå®äºåŸããã®åå¿æ··å
ç©ãïŒâã«ä¿ã€ãŠããã«1.5æéæªæããã ãã®åŸæ¿å¡©é žãå ããããšã«ããåå¿æ··åç©ã
çŽããšé žæ§åãããããã«30åæªæåŸãåå¿æ··å
ç©ã40âã«æããŠ1/3ã®å®¹éã«ãªããŸã§æžå§äžã«
æ¿çž®ããã ãã®æ¿çž®æ··åç©ã¯æ¬¡ãã§æ°·æµŽäžã§å·åŽããŠã¯ã
ã«ã¢ã»ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ãæåºãã
ããæ°Žã§ïŒåæŽæµåŸãã¯ãã«ã¢ã»ãã«ã°ãªã·ã«ã°
ãªã·ã«ã°ãªã·ã³2.75ïœïŒåºçºæ··åç©äžã«æº¶è§£ãã
ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ã®éã«åºã¥ããŠåç
78.5ïŒ ïŒãåŸãã 次ã«ãçªçŽ é°å²æ°äžã§ç²ã¯ãã«ã¢ã»ãã«ã°ãªã·
ã«ã°ãªã·ã«ã°ãªã·ã³ïŒïœãç¡æ°Žã¡ã¿ããŒã«300ml
ã«æº¶è§£ããããã®ãã©ã¹ã³ã«ããªå®æ¯éŠé žãããª
ãŠã å«æ溶液ïŒã¡ã¿ããŒã«äžã®ãããªãŠã 175mg
ã«ããªå®æ¯éŠé ž1.1ïœãæ·»å ããŠèª¿è£œãããã®ïŒ
50mlãå ãããã®åå¿æ··åç©ã1.5æééæµããã ãã®åŸæº¶åªãæžå§äžã«é€å»ãããåŸãããåºäœ
ãéã«ããåé¢ããã¯ãããã«ã ã§æŽã€ããã¡
ã¿ããŒã«ããçµæ¶åãããŠãã³ãŸã€ã«ã¡ã«ã«ãã
ã¢ã»ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³1.25ïœïŒ90
ïŒ ïŒãååããã ã¡ã¿ããŒã«ããã®çµæ¶åã§åŸãããçæç©ãã
ã³ãŸã€ã«ã¡ã«ã«ããã¢ã»ãã«ã°ãªã·ã«ã°ãªã·ã«ã°
ãªã·ã³ã§ããããšã蚌æããããã«å çŽ åæãè¡
ã€ãããã³ãŸã€ã«ã¡ã«ã«ããã¢ã»ãã«ã°ãªã·ã«ã°
ãªã·ã«ã°ãªã·ã³ãæ§æããççŽ ãæ°ŽçŽ ãçªçŽ ãã
ã³ç¡«é»ã®èšç®ããçè«å€ïŒïŒ ïŒã¯ãããã56.56ã
4.92ã5.74ããã³13.11ã§ãããå çŽ åæã®çµæã¯
ãããã6.50ã5.06ã5.67ããã³13.27ã§ãã€ãã
çè«å€ãšå®æž¬å€ãšãå®è³ªçäžèŽããããšã«ããã
ãã®åå¿é åºã®çæç©ããã³ãŸã€ã«ã¡ã«ã«ããã¢
ã»ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ã§ãããšå€æã
ãã å®æœäŸ ïŒ Tcâ99mã¡ã«ã«ããã¢ã»ãã«ã°ãªã·ã«ã°ãªã·
ã«ã°ãªã·ã³ã®åæ å ã«è¿°ã¹ãããã«ãæ¬çºæã®ïŒã€ã®éèŠãªç¹åŸŽ
ã¯æå³ããã€ã¡ãŒãžã³ã°è¬å€ã®åé§äœããããã®
圢ã§å è£ ã§ããããšã§ããããã®å®æœäŸã¯ã€ã¡ãŒ
ãžã³ã°è¬å€ãšããŠã®Tcâ99mâMAGGGã«é¢ä¿
ãããã®çš®ã®ãããã®è£œé ã«ã€ããŠç€ºãã äŸãã°ãçŽ100åã®ããããäœãå Žåã«ã¯ã
1.25M亀æãªã¬ã³ãäžéäœïŒã¢ã»ããŒããã°ãªã·
ã³ãã·ãã¬ãŒããããããŒããã°ã«ã³ããŒããã°
ã«ã³ãããããŒããããã¹ããšãŒããã¿ã«ãã¬ãŒ
ãããã¬ãšãŒããã©ã¯ããŒããããããã·ã€ãœã
ãã¬ãŒãããŸãã¯ïŒ®âã¡ãã«ïŒ®ïŒNâ²âãã¹ïŒïŒ
âããããã·ãšãã«ïŒãšãã¬ã³ãžã¢ãã³ãªã©ïŒ80
mlãçŽPH5.5ã«èª¿ç¯ãã次ã«çªçŽ ã¬ã¹ãæ£åžãã
ããšã«ãã€ãŠè±é µçŽ ããããã®åŸãã³ãŸã€ã«ã¡ã«
ã«ããã¢ã»ãã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³100mg
ãå ããéæ溶液ãåŸããããŸã§æªæããã 次ã«ã0.1Nå¡©é žïŒmläžã®SnCl2ã»2H2Oã®æ°ã
ã調補ãã10mgïŒml溶液0.2mlããã®æ··åç©ã«çª
çŽ é°å²æ°äžã§å ãããæåŸã«ãåŸãããæ··åç©ã¯
0.1N HClãŸãã¯NaOHã®é©éãå ããããšã«ã
ã€ãŠçŽPHïŒã«èª¿ç¯ããå šå®¹éã100mlãšãããã
ã«åžéãããããŠçªçŽ é°å²æ°ãä¿ã¡ãªãã0.2ã
ã¯ãã³ã®ãã€ã«ã¿ãŒãééãããŠæ» èããã10ml
ã®ã¢ãªã³ãŒããç¡èæè¡ãçšããŠãã€ã¢ã«ã«åé
ããåã ã®ã¢ãªã³ãŒãã¯ä¿åã®ããã«åçµãŸãã¯
åçµä¹Ÿç¥ãããå Žåã«ãã€ãŠã¯ã第äžé«ã€ãªã³å®
å®å€ïŒã²ã³ãã·ã³é žãŸãã¯ã¢ã¹ã³ã«ãã³é žãªã©ïŒ
ãå ããŠãããã Moâ99ïŒTcâ99mçºçå€ããææã¬ãã«ã®æŸ
å°èœãæããå¡©æ°Žäžã®Tcâ99méãã¯ãããŠã
é žå¡©çŽïŒãïŒmlãçæããåè¿°ã®ããã«ããŠèª¿è£œ
ããåå¿å€ãå«ããã€ã¢ã«ã®ïŒã€ã«æ·»å ãããæ··
å液ãTcâ99mâMAGGGãçæãããããã«
ãã®ãã€ã¢ã«ã沞隰氎济äžã«ïŒåéå ¥ããããã®
調補ç©ãå·åŽãããã以äžã®åŠçãè¡ãããšãªã
䜿çšããã å®æœäŸ ïŒ åææ¹æ³ ææãªãã°ãTcâ99mâMAGGGã®æ¥åžžåæ
ãããã·ã¬ã³å·ã¢ã³ã¢ãŒããŒã®ã²ã«ãã³ç€Ÿ
ïŒGelmanïŒInc.ïŒããå ¥æã§ãããããªITLCâ
SGã·ãªã«ã²ã«å«æµžã¬ã©ã¹ãã¢ã€ããŒã¹ããªãã
ã§ã®èå±€ã¯ãããã°ã©ãã€ãŒãçšããŠæå©ã«è¡ã
ããã å¯æº¶æ§ã®éçµåTcâ99méãã¯ãããŠã é žå¡©
ã®éã¯ãã¡ãã«ãšãã«ã±ãã³ã§å±éããã¹ããªã
ãã®æº¶åªå 端ã®æŸå°èœã枬å®ããããšã«ããåŸã
ãããäžæº¶æ§Tcâ99mã®éã¯ãå¡©æ°Žã§å±éãã
ã¹ããªããã®åç¹ç»åããæŸå°èœã枬å®ããããš
ã«ããåŸããããçµåTcâ99mã®çŸåçã¯æ¬¡ã®
åŒïŒ ïŒ çµåïŒ100âïŒ éçµåâïŒ äžæº¶æ§ ã«åŸã€ãŠèšç®ããã ãã¬ãŒãåTcâ99mâMAGGGçæç©ã®åæ
ã¯ãïŒãã¯ãã³ã®ODSã«ã©ã ãšå ±ã«ïŒïŒ ãšã¿ã
ãŒã«ïŒ95ïŒ 0.01Mçé žå¡©ïŒPHïŒïŒãããªã溶åªç³»
ã䜿çšããé«æ§èœæ¶²äœã¯ãããã°ã©ãã€ãŒ
ïŒHPLCïŒãçšããŠè¡ãããšãã§ãããTcâ99m
âMAGGGã¯1.0mlïŒåã®æµéã®å ŽåçŽïŒåã§äž»
èŠããŒã¯ãšãªãã芳å¯ãããä»ã®æåã¯çŽ2.5å
ã§ã®Tcâ99méãã¯ãããŠã é žå¡©ã§ããã å®æœäŸ ïŒ æ£åžžããŠã¹ã«ãããTcâ99mâMAGGGã®è
èã«ããå蟌㿠ïŒçŸ€ïŒå¹ã®ããŠã¹ïŒçŸ€ã«Tcâ99mâMAGGG
ãšïŒ©â131 OIHïŒæšæºå¯Ÿç §ïŒãšãåæã«æäžã
ããåããŠã¹ã«ã¯0.5ãã€ã¯ãããŠãªãŒã®Tcâ
99mâMAGGGããã³0.2ãã€ã¯ãããŠãªãŒã®ïŒ©
â131 OIHãå«æãã調補ç©0.1mlãéèå 泚å°
ãããã®åŸææ³ãããå°¿ãååã§ãã代è¬ã²ãŒãž
ã®äžã«å ¥ããã 泚å°ã®10ååŸã«åããŠã¹ã®å°¿éãçµã³ããããŠ
ã¯ãããã«ã èžæ°ã«ãã€ãŠããŠã¹ã殺ããã次
ã«ãæŸå°èœæšèããç©è³ªã®çç©ååžã調ã¹ããã
ã«çš®ã ã®ãµã³ãã«ãæ¡åããããããã®ãµã³ãã«
ã®çµæãè¡šã«ç€ºãã泚å°ã®120ååŸã«ç¬¬ïŒçŸ€ã®
ããŠã¹ã«å¯ŸããŠåæ§ã®æž¬å®ãè¡ãããã®çµæãè¡š
ã«ç€ºãã
ãè¡šã
ãè¡šã
è¡šããã³è¡šã¯Tcâ99mâMAGGGãè
è
ã«ãã€ãŠè¿ éã«ãã€éžæçã«é€å»ãããã»ãã®åŸ®
éãä»ã®äž»èŠèåšã«å蟌ãŸããã«ãããªãããšã
瀺ããŠããããã®ããšã¯ã€ã¡ãŒãžã³ã°è¬å€ã®éèŠ
ãªæ§è³ªã§ãããããããŠæŸå°æ§æšèã«ãã€ãŠæŸå°
ãããæŸå°ç·ããçäœçµç¹ãžã®æå·ãåé¿ããã
ã€é©åœãªæ åãåŸãã®ã«å¿ èŠãšãããæŸå°æ§å»è¬
åã®æäžéãæå°éã«æããããšãã§ããã ãŸãããããã®è¡šããæãããªããã«ãTcâ
99mâMAGGGã¯ïŒ©â131 OIHãããããªãè¿ é
ã«è èããææ³ãããã10åããã³120åã§ã®å°¿
äžã®Tcâ99mâMAGGGã®ã¬ãã«ã¯ïŒ©â131
OIHã®å¯Ÿå¿ããã¬ãã«ã®107.3ïŒ ããã³102.6ïŒ ã«
çããã€ããåŸã€ãŠTcâ99mã¯ïŒ©â131ãããçµ
ç¹ãžã®æå·ãå°ãªããŠããã®ã§ããããã®çµæã¯
Tcâ99mâMAGGGã®æ¹ãâ131 OIHããã
䜿çšäžããªãå®å šã§ããããšã瀺ããŠããã å®æœäŸ ïŒ ããããã·ãåŠçããŠã¹ã«ãããTcâ99mâ
MAGGGã®è èã«ããå蟌㿠尿现管茞éãé»å®³ããããŠã¹ã«ãããŠTcâ
99mâMAGGGã®çç©ååžãè©Šéšããããã«ãïŒ
å¹ã®ããŠã¹ã«äœéïŒKgåœããããããã·ã
ïŒprobenicidïŒ50mgã®å²åã§ããããã·ã溶液ã
泚å°ããã10ååŸãåããŠã¹ã«0.5ãã€ã¯ãããŠ
ãªãŒã®Tcâ99mâMAGGGããã³0.2ãã€ã¯ãã
ãŠãªãŒïŒ©â131 OIHãå«æãã溶液0.1mlã泚å°
ãããããã«10ååŸãåããŠã¹ã殺ããŠæŸå°æ§ç©
質ã®çç©ååžã調ã¹ãããã«çš®ã ã®ãµã³ãã«ãæ¡
åããããããã®ãµã³ãã«ã®çµæãè¡šã«ç€ºãã
ã«ãã€ãŠè¿ éã«ãã€éžæçã«é€å»ãããã»ãã®åŸ®
éãä»ã®äž»èŠèåšã«å蟌ãŸããã«ãããªãããšã
瀺ããŠããããã®ããšã¯ã€ã¡ãŒãžã³ã°è¬å€ã®éèŠ
ãªæ§è³ªã§ãããããããŠæŸå°æ§æšèã«ãã€ãŠæŸå°
ãããæŸå°ç·ããçäœçµç¹ãžã®æå·ãåé¿ããã
ã€é©åœãªæ åãåŸãã®ã«å¿ èŠãšãããæŸå°æ§å»è¬
åã®æäžéãæå°éã«æããããšãã§ããã ãŸãããããã®è¡šããæãããªããã«ãTcâ
99mâMAGGGã¯ïŒ©â131 OIHãããããªãè¿ é
ã«è èããææ³ãããã10åããã³120åã§ã®å°¿
äžã®Tcâ99mâMAGGGã®ã¬ãã«ã¯ïŒ©â131
OIHã®å¯Ÿå¿ããã¬ãã«ã®107.3ïŒ ããã³102.6ïŒ ã«
çããã€ããåŸã€ãŠTcâ99mã¯ïŒ©â131ãããçµ
ç¹ãžã®æå·ãå°ãªããŠããã®ã§ããããã®çµæã¯
Tcâ99mâMAGGGã®æ¹ãâ131 OIHããã
䜿çšäžããªãå®å šã§ããããšã瀺ããŠããã å®æœäŸ ïŒ ããããã·ãåŠçããŠã¹ã«ãããTcâ99mâ
MAGGGã®è èã«ããå蟌㿠尿现管茞éãé»å®³ããããŠã¹ã«ãããŠTcâ
99mâMAGGGã®çç©ååžãè©Šéšããããã«ãïŒ
å¹ã®ããŠã¹ã«äœéïŒKgåœããããããã·ã
ïŒprobenicidïŒ50mgã®å²åã§ããããã·ã溶液ã
泚å°ããã10ååŸãåããŠã¹ã«0.5ãã€ã¯ãããŠ
ãªãŒã®Tcâ99mâMAGGGããã³0.2ãã€ã¯ãã
ãŠãªãŒïŒ©â131 OIHãå«æãã溶液0.1mlã泚å°
ãããããã«10ååŸãåããŠã¹ã殺ããŠæŸå°æ§ç©
質ã®çç©ååžã調ã¹ãããã«çš®ã ã®ãµã³ãã«ãæ¡
åããããããã®ãµã³ãã«ã®çµæãè¡šã«ç€ºãã
ãè¡šã
è¡šã¯æ©èœçã«å£ã€ãè
èã§ãã€ãŠããªãâ
131 OIHããTcâ99mâMAGGGãå€éã«é€å»
ã§ããããšã瀺ããŠãããâ131ã¯ä»ã®æŸå°æ§
å»è¬åã枬å®ããå Žåã®ç®äžã®æšæºã§ããããã
ãããã®çµæã¯Tcâ99mâMAGGGãè æ©èœã®
蚺ææ¹æ³ã«ãããŠäœ¿çšããããã®åªããååç©ã§
ããããšã瀺ããŠããã å®æœäŸ ïŒããã³ïŒ ããã«ãããTcâ99mâMAGGGã®è èã«ã
ãææ³ ããã®Tcâ99mâMAGGGã®è èææ³ã¯æ£åžž
ãªå¿é¡è ã«ããå®éšã«åºã¥ããŠåŸããããæ¯èŒã®
ããã«ãTcâ99mâMAGGGã䜿çšããè©Šéšã®
çŽåãŸãã¯çŽåŸã«ïŒ©â131 OIHã䜿çšããè©Šéš
ãè¡ã€ãã å®æœäŸïŒã§ã¯ãå®æœäŸïŒã«èšèŒã®æ¹æ³ãšé¡äŒŒã
ã第äžé«éå ïŒäº€æãªã¬ã³ãäžéäœãšããŠã¯ã°ã«
ã³ãžããããŒãã䜿çšïŒã«ããTcâ99mâ
MAGGGã補é ãããå®æœäŸïŒã§ã¯ã第äžé«é
å ã䜿çšãã代ããã«éå å€ãšããŠäºäºããªã³é ž
å¡©ã䜿çšãããäž¡å®æœäŸãšãHPLCã«ã©ã ã§åã
äž»èŠããŒã¯ãæããTcâ99mâMAGGGãäžã
ãã äž¡å®æœäŸã«ãããŠã被éšè ã«ã¯çŽ15ããªããŠãª
ãŒã®Tcâ99mâMAGGGãå«ãçšéã泚å°ããã
â131 OIHãå©çšããæ¯èŒè©Šéšã§ã¯çŽ300ãã€
ã¯ãããŠãªãŒã®ïŒ©â131 OIHãæäžãããäž¡æ¹
ã®å ŽåãšããçŽ30åéã«ããã€ãŠè èã尿管ãã
ã³è¡æ¶²ããŒã«ã®ã€ã¡ãŒãžã³ã°ãè¡ããç¶ããŠèè±
ã§ã®èšæ°çã枬å®ããã ãã®åŸèè±ã空ã«ããŠãæ®çæŸå°èœã®ååšãæ€
åºããããã«è¿œå ã®æ åããšããããããŠ30åã§
ã®å°¿æŸå°èœã®çŸåçã枬å®ãããïŒæéã§ãåæ§
ã®æž¬å®ãè¡ã€ãããããã®è©Šéšã®çµæãè¡šã«ç€º
ãã
131 OIHããTcâ99mâMAGGGãå€éã«é€å»
ã§ããããšã瀺ããŠãããâ131ã¯ä»ã®æŸå°æ§
å»è¬åã枬å®ããå Žåã®ç®äžã®æšæºã§ããããã
ãããã®çµæã¯Tcâ99mâMAGGGãè æ©èœã®
蚺ææ¹æ³ã«ãããŠäœ¿çšããããã®åªããååç©ã§
ããããšã瀺ããŠããã å®æœäŸ ïŒããã³ïŒ ããã«ãããTcâ99mâMAGGGã®è èã«ã
ãææ³ ããã®Tcâ99mâMAGGGã®è èææ³ã¯æ£åžž
ãªå¿é¡è ã«ããå®éšã«åºã¥ããŠåŸããããæ¯èŒã®
ããã«ãTcâ99mâMAGGGã䜿çšããè©Šéšã®
çŽåãŸãã¯çŽåŸã«ïŒ©â131 OIHã䜿çšããè©Šéš
ãè¡ã€ãã å®æœäŸïŒã§ã¯ãå®æœäŸïŒã«èšèŒã®æ¹æ³ãšé¡äŒŒã
ã第äžé«éå ïŒäº€æãªã¬ã³ãäžéäœãšããŠã¯ã°ã«
ã³ãžããããŒãã䜿çšïŒã«ããTcâ99mâ
MAGGGã補é ãããå®æœäŸïŒã§ã¯ã第äžé«é
å ã䜿çšãã代ããã«éå å€ãšããŠäºäºããªã³é ž
å¡©ã䜿çšãããäž¡å®æœäŸãšãHPLCã«ã©ã ã§åã
äž»èŠããŒã¯ãæããTcâ99mâMAGGGãäžã
ãã äž¡å®æœäŸã«ãããŠã被éšè ã«ã¯çŽ15ããªããŠãª
ãŒã®Tcâ99mâMAGGGãå«ãçšéã泚å°ããã
â131 OIHãå©çšããæ¯èŒè©Šéšã§ã¯çŽ300ãã€
ã¯ãããŠãªãŒã®ïŒ©â131 OIHãæäžãããäž¡æ¹
ã®å ŽåãšããçŽ30åéã«ããã€ãŠè èã尿管ãã
ã³è¡æ¶²ããŒã«ã®ã€ã¡ãŒãžã³ã°ãè¡ããç¶ããŠèè±
ã§ã®èšæ°çã枬å®ããã ãã®åŸèè±ã空ã«ããŠãæ®çæŸå°èœã®ååšãæ€
åºããããã«è¿œå ã®æ åããšããããããŠ30åã§
ã®å°¿æŸå°èœã®çŸåçã枬å®ãããïŒæéã§ãåæ§
ã®æž¬å®ãè¡ã€ãããããã®è©Šéšã®çµæãè¡šã«ç€º
ãã
ãè¡šã
è¡šã¯Tcâ99mâMAGGGãããã®å Žåã«ã
é«ãè èåžåçãæãããããâ131 OIHã
ãããªãåªããŠããããšãæ確ã«ç€ºããŠãããã
ã®ããšã¯Tcâ99mâMAGGGãã·ã³ãã°ã©ãã€
âå°¿è·¯é 圱æ³çšã®ååºããã€ã¡ãŒãžã³ã°è¬å€ã§ã
ãããšã瀺ãããããšã¯å¯Ÿç §çã«ãæ¬çºæ以åã®
Tcâ99mååç©ã¯æãå¹çããææ³ããããã®
ã§ãã€ãŠãâ131 OIHãã20ïŒ è¿ãããã®æ
æ³çãå£ã€ãŠããã å®æœäŸ ïŒ Tcâ99mâMAGGGã®åæããã³è èã§ã®å
蟌㿠Tcâ99mâMAGGGã®åæã«é¢ããŠåèšåå¿
åŒãªãã³ã«å®æœäŸïŒããã³ïŒã§èª¬æããäžè¬çå
æå·¥çšã«åŸã€ãŠãTcâ99mâã¡ã«ã«ããã¢ã»ã
ã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ïŒTcâ
99mâMAGGGGïŒã補é ãããããã¯å®æœäŸïŒ
ã®ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ã®ä»£ããã«ã°ãªã·ã«
ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ãçšããŠéæããã 次ãã§ãå®æœäŸïŒã«èšèŒã®æ¹æ³ãšé¡äŒŒããæ¹æ³
ãçšããŠTcâ99mâMAGGGGãããŠã¹ã«æäž
ããã泚å°ã®10ååŸããã³120åŸã«çç©ååžã®æž¬
å®ãè¡ã€ãããããã®æž¬å®çµæãè¡šã«ç€ºãã
é«ãè èåžåçãæãããããâ131 OIHã
ãããªãåªããŠããããšãæ確ã«ç€ºããŠãããã
ã®ããšã¯Tcâ99mâMAGGGãã·ã³ãã°ã©ãã€
âå°¿è·¯é 圱æ³çšã®ååºããã€ã¡ãŒãžã³ã°è¬å€ã§ã
ãããšã瀺ãããããšã¯å¯Ÿç §çã«ãæ¬çºæ以åã®
Tcâ99mååç©ã¯æãå¹çããææ³ããããã®
ã§ãã€ãŠãâ131 OIHãã20ïŒ è¿ãããã®æ
æ³çãå£ã€ãŠããã å®æœäŸ ïŒ Tcâ99mâMAGGGã®åæããã³è èã§ã®å
蟌㿠Tcâ99mâMAGGGã®åæã«é¢ããŠåèšåå¿
åŒãªãã³ã«å®æœäŸïŒããã³ïŒã§èª¬æããäžè¬çå
æå·¥çšã«åŸã€ãŠãTcâ99mâã¡ã«ã«ããã¢ã»ã
ã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ïŒTcâ
99mâMAGGGGïŒã補é ãããããã¯å®æœäŸïŒ
ã®ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ã®ä»£ããã«ã°ãªã·ã«
ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ãçšããŠéæããã 次ãã§ãå®æœäŸïŒã«èšèŒã®æ¹æ³ãšé¡äŒŒããæ¹æ³
ãçšããŠTcâ99mâMAGGGGãããŠã¹ã«æäž
ããã泚å°ã®10ååŸããã³120åŸã«çç©ååžã®æž¬
å®ãè¡ã€ãããããã®æž¬å®çµæãè¡šã«ç€ºãã
ãè¡šã
10åããã³120åã§ã®Tcâ99mâMAGGGGã®
å°¿äžã¬ãã«ã¯ããããâ131 OIHã®å¯Ÿå¿ã¬ã
ã«ã®86.7ïŒ ããã³87.6ïŒ ã«çããããã®ååç©ã
â131 OIHã®ä»£æ¿ç©ã«ãªãåŸãããšã瀺ããŠ
ãããããããè žã®æŸå°èœã«ãã€ãŠç€ºããããã
ãªèèæ±æ§ææ³ã®å¢å ã¯ç¹ç°æ§ã®äœäžã瀺ããŠã
ãã å®æœäŸ ïŒ Tcâ99mâMAGGâã¢ã©ãã³ã®åæããã³è
èã«ããå蟌㿠åèšåå¿åŒãå®æœäŸïŒããã³ïŒã«èšèŒã®äžè¬å
æå·¥çšã«åŸãããã€å®æœäŸïŒã®ã°ãªã·ã«ã°ãªã·ã«
ã°ãªã·ã³ã®ä»£ããã«ã°ãªã·ã«ã°ãªã·ã«ã¢ã©ãã³ã
çšããŠãTcâ99mâã¡ã«ã«ããã¢ã»ãã«ã°ãªã·
ã«ã°ãªã·ã«ã¢ã©ãã³ã補é ããã ãã®åŸãå®æœäŸïŒã«èšèŒã®æ¹æ³ãšé¡äŒŒããæ¹æ³
ã«ããTcâ99mâMAGGâã¢ã©ãã³ãããŠã¹ã«
æäžããã泚å°ã®10ååŸããã³120ååŸã«çç©å
åžã枬å®ããããããã®æž¬å®çµæãè¡šã«ç€ºãã
å°¿äžã¬ãã«ã¯ããããâ131 OIHã®å¯Ÿå¿ã¬ã
ã«ã®86.7ïŒ ããã³87.6ïŒ ã«çããããã®ååç©ã
â131 OIHã®ä»£æ¿ç©ã«ãªãåŸãããšã瀺ããŠ
ãããããããè žã®æŸå°èœã«ãã€ãŠç€ºããããã
ãªèèæ±æ§ææ³ã®å¢å ã¯ç¹ç°æ§ã®äœäžã瀺ããŠã
ãã å®æœäŸ ïŒ Tcâ99mâMAGGâã¢ã©ãã³ã®åæããã³è
èã«ããå蟌㿠åèšåå¿åŒãå®æœäŸïŒããã³ïŒã«èšèŒã®äžè¬å
æå·¥çšã«åŸãããã€å®æœäŸïŒã®ã°ãªã·ã«ã°ãªã·ã«
ã°ãªã·ã³ã®ä»£ããã«ã°ãªã·ã«ã°ãªã·ã«ã¢ã©ãã³ã
çšããŠãTcâ99mâã¡ã«ã«ããã¢ã»ãã«ã°ãªã·
ã«ã°ãªã·ã«ã¢ã©ãã³ã補é ããã ãã®åŸãå®æœäŸïŒã«èšèŒã®æ¹æ³ãšé¡äŒŒããæ¹æ³
ã«ããTcâ99mâMAGGâã¢ã©ãã³ãããŠã¹ã«
æäžããã泚å°ã®10ååŸããã³120ååŸã«çç©å
åžã枬å®ããããããã®æž¬å®çµæãè¡šã«ç€ºãã
ãè¡šã
10åããã³ã³120åã§ã®Tcâ99mâMAGGâ
ã¢ã©ãã³ã®å°¿äžã¬ãã«ã¯ããããâ131 OIH
ã®å¯Ÿå¿ã¬ãã«ã®106.4ïŒ ããã³102.2ïŒ ã«çããã
ãã®ååç©ãã·ã³ãã°ã©ãã€ãŒå°¿è·¯é 圱æ³ã§ã®äœ¿
çšã«ãããŠïŒ©â131 OIHã®ä»£æ¿ç©ãšããŠåªããŠ
ããããšã瀺ããŠããã å®æœäŸ 10 Tcâ99mâMAGGâã¢ã¹ãã©ã®ã³é žã®åæã
ãã³è èã«ããå蟌㿠åèšåå¿åŒãå®æœäŸïŒããã³ïŒã«èšèŒã®äžè¬å
æå·¥çšã«åŸããã€å®æœäŸïŒã®ã°ãªã·ã«ã°ãªã·ã«ã°
ãªã·ã³ã®ä»£ããã«ã°ãªã·ã«ã°ãªã·ã«ã¢ã¹ãã©ã®ã³
é žãçšããŠãTcâ99mâã¡ã«ã«ããã¢ã»ãã«ã°
ãªã·ã«ã°ãªã·ã«ã¢ã¹ãã©ã®ã³é žã補é ããã ãã®åŸãTcâ99mâMAGGâã¢ã¹ãã©ã®ã³é ž
ãå®æœäŸïŒã«èšèŒã®æ¹æ³ãšé¡äŒŒããæ¹æ³ãçšããŠ
ããŠã¹ã«æäžãããçç©ååžã®æž¬å®çµæãè¡šã«
瀺ãã
ã¢ã©ãã³ã®å°¿äžã¬ãã«ã¯ããããâ131 OIH
ã®å¯Ÿå¿ã¬ãã«ã®106.4ïŒ ããã³102.2ïŒ ã«çããã
ãã®ååç©ãã·ã³ãã°ã©ãã€ãŒå°¿è·¯é 圱æ³ã§ã®äœ¿
çšã«ãããŠïŒ©â131 OIHã®ä»£æ¿ç©ãšããŠåªããŠ
ããããšã瀺ããŠããã å®æœäŸ 10 Tcâ99mâMAGGâã¢ã¹ãã©ã®ã³é žã®åæã
ãã³è èã«ããå蟌㿠åèšåå¿åŒãå®æœäŸïŒããã³ïŒã«èšèŒã®äžè¬å
æå·¥çšã«åŸããã€å®æœäŸïŒã®ã°ãªã·ã«ã°ãªã·ã«ã°
ãªã·ã³ã®ä»£ããã«ã°ãªã·ã«ã°ãªã·ã«ã¢ã¹ãã©ã®ã³
é žãçšããŠãTcâ99mâã¡ã«ã«ããã¢ã»ãã«ã°
ãªã·ã«ã°ãªã·ã«ã¢ã¹ãã©ã®ã³é žã補é ããã ãã®åŸãTcâ99mâMAGGâã¢ã¹ãã©ã®ã³é ž
ãå®æœäŸïŒã«èšèŒã®æ¹æ³ãšé¡äŒŒããæ¹æ³ãçšããŠ
ããŠã¹ã«æäžãããçç©ååžã®æž¬å®çµæãè¡šã«
瀺ãã
ãè¡šã
10åããã³120åã§ã®Tcâ99mâMAGGâã¢
ã¹ãã©ã®ã³é žã®å°¿äžã¬ãã«ã¯ããããâ131
OIHã®å¯Ÿå¿ã¬ãã«ã®64.2ïŒ ããã³94.1ïŒ ã«çãã
ã€ãã10åã§ã®äœãææ³ãããããšãâ131
OIHã®ä»£æ¿ç©ãšããŠã®ãã®ååç©ã®é©åæ§ã¯ç
ãããã å®æœäŸ 11 Tcâ99mâMAGGâã°ã«ã¿ãã³ã®åæããã³
è èã«ããå蟌㿠åèšåå¿åŒãªãã³ã«å®æœäŸïŒããã³ïŒã«èšèŒã®
äžè¬åæå·¥çšã«åŸããã€å®æœäŸïŒã®ã°ãªã·ã«ã°ãª
ã·ã«ã°ãªã·ã³ã®ä»£ããã«ã°ãªã·ã«ã°ãªã·ã«ã°ã«ã¿
ãã³ã䜿çšããŠãTcâ99mâMAGGâã°ã«ã¿ã
ã³ã補é ããã ãã®åŸãTcâ99mâMAGGâã°ã«ã¿ãã³ãå®
æœäŸïŒã«èšèŒã®æ¹æ³ãšé¡äŒŒããæ¹æ³ãçšããŠããŠ
ã¹ã«æäžãããçç©ååžã®æž¬å®çµæãè¡šã«ç€º
ãã
ã¹ãã©ã®ã³é žã®å°¿äžã¬ãã«ã¯ããããâ131
OIHã®å¯Ÿå¿ã¬ãã«ã®64.2ïŒ ããã³94.1ïŒ ã«çãã
ã€ãã10åã§ã®äœãææ³ãããããšãâ131
OIHã®ä»£æ¿ç©ãšããŠã®ãã®ååç©ã®é©åæ§ã¯ç
ãããã å®æœäŸ 11 Tcâ99mâMAGGâã°ã«ã¿ãã³ã®åæããã³
è èã«ããå蟌㿠åèšåå¿åŒãªãã³ã«å®æœäŸïŒããã³ïŒã«èšèŒã®
äžè¬åæå·¥çšã«åŸããã€å®æœäŸïŒã®ã°ãªã·ã«ã°ãª
ã·ã«ã°ãªã·ã³ã®ä»£ããã«ã°ãªã·ã«ã°ãªã·ã«ã°ã«ã¿
ãã³ã䜿çšããŠãTcâ99mâMAGGâã°ã«ã¿ã
ã³ã補é ããã ãã®åŸãTcâ99mâMAGGâã°ã«ã¿ãã³ãå®
æœäŸïŒã«èšèŒã®æ¹æ³ãšé¡äŒŒããæ¹æ³ãçšããŠããŠ
ã¹ã«æäžãããçç©ååžã®æž¬å®çµæãè¡šã«ç€º
ãã
ãè¡šã
10åããã³120åã§ã®Tcâ99mâMAGGâã°
ã«ã¿ãã³ã®å°¿äžã¬ãã«ã¯ããããâ131 OIH
ã®å¯Ÿå¿ã¬ãã«ã®97.6ïŒ ããã³103.4ïŒ ã«çããã
ãã®ååç©ãã·ã³ãã°ã©ãã€ãŒå°¿è·¯é 圱æ³ã§ã®äœ¿
çšã«ãããŠïŒ©â131 OIHã®ä»£æ¿ç©ãšããŠåªããŠ
ããããšã瀺ããŠããã å®æœäŸ 12 Tcâ99mâMAGGâããšãã«ã¢ã©ãã³ã®åæ
ããã³è èã«ããå蟌㿠åèšåå¿åŒããã³å®æœäŸïŒããã³ïŒã«èšèŒã®äž
è¬åæå·¥çšã«åŸã€ãŠTcâ99mâMAGGâããšã
ã«ã¢ã©ãã³ã補é ããããã ãå®æœäŸïŒã®ã°ãªã·
ã«ã°ãªã·ã«ã°ãªã·ã³ã®ä»£ããã«ã°ãªã·ã«ã°ãªã·ã«
ããšãã«ã¢ã©ãã³ã䜿çšããã Tcâ99mâMAGGâããšãã«ã¢ã©ãã³ã¯ïŒã€
ã®åé¢å¯èœãªãžã¢ã¹ãã¬ãªããŒïŒèšå·âããã³
âã§åºå¥ããïŒãšããŠååšããããžã¢ã¹ãã¬ãª
ããŒTcâ99âMAGGâããšãã«ã¢ã©ãã³âãš
Tcâ99mâMAGGâããšãã«ã¢ã©ãã³âãšã
åé¢ããŠãå®æœäŸïŒã«èšèŒã®æ¹æ³ãšé¡äŒŒããæ¹æ³
ãçšããŠããŠã¹ã«æäžããããããïŒã€ã®ååç©
ã«å¯Ÿããçç©ååžã®æž¬å®çµæãããããè¡šãã
ã³ã«ç€ºãã
ã«ã¿ãã³ã®å°¿äžã¬ãã«ã¯ããããâ131 OIH
ã®å¯Ÿå¿ã¬ãã«ã®97.6ïŒ ããã³103.4ïŒ ã«çããã
ãã®ååç©ãã·ã³ãã°ã©ãã€ãŒå°¿è·¯é 圱æ³ã§ã®äœ¿
çšã«ãããŠïŒ©â131 OIHã®ä»£æ¿ç©ãšããŠåªããŠ
ããããšã瀺ããŠããã å®æœäŸ 12 Tcâ99mâMAGGâããšãã«ã¢ã©ãã³ã®åæ
ããã³è èã«ããå蟌㿠åèšåå¿åŒããã³å®æœäŸïŒããã³ïŒã«èšèŒã®äž
è¬åæå·¥çšã«åŸã€ãŠTcâ99mâMAGGâããšã
ã«ã¢ã©ãã³ã補é ããããã ãå®æœäŸïŒã®ã°ãªã·
ã«ã°ãªã·ã«ã°ãªã·ã³ã®ä»£ããã«ã°ãªã·ã«ã°ãªã·ã«
ããšãã«ã¢ã©ãã³ã䜿çšããã Tcâ99mâMAGGâããšãã«ã¢ã©ãã³ã¯ïŒã€
ã®åé¢å¯èœãªãžã¢ã¹ãã¬ãªããŒïŒèšå·âããã³
âã§åºå¥ããïŒãšããŠååšããããžã¢ã¹ãã¬ãª
ããŒTcâ99âMAGGâããšãã«ã¢ã©ãã³âãš
Tcâ99mâMAGGâããšãã«ã¢ã©ãã³âãšã
åé¢ããŠãå®æœäŸïŒã«èšèŒã®æ¹æ³ãšé¡äŒŒããæ¹æ³
ãçšããŠããŠã¹ã«æäžããããããïŒã€ã®ååç©
ã«å¯Ÿããçç©ååžã®æž¬å®çµæãããããè¡šãã
ã³ã«ç€ºãã
ãè¡šã
ãè¡šã
10åããã³120åã§ã®Tcâ99mâMAGGâã
ãšãã«ã¢ã©ãã³âã®å°¿äžã¬ãã«ã¯ããããâ
131 OIHã®å¯Ÿå¿ã¬ãã«ã®43.9ïŒ ããã³73.5ïŒ ã«ç
ããã€ãã10ããã³120åã§ã®Tcâ99mâ
MAGGâããšãã«ã¢ã©ãã³âã®å°¿äžã¬ãã«ã¯
ããããâ131 OIHã®å¯Ÿå¿ã¬ãã«ã®22.0ããã³
52.3ïŒ ã«çããã€ãããããã®äœãçŸåçã¯ãã
ããã®ååç©ã®ææéãçš®ã ã®çµç¹ã«å蟌ãŸãã
ããšã瀺ãçç©ååžã®æž¬å®çµæãšå ±ã«ãTcâ
99mâMAGGâããšãã«ã¢ã©ãã³ãäžè¬ã®ã·ã³
ãã°ã©ãã€ãŒå°¿è·¯é 圱æ³ã§ã®æ¥åžžäœ¿çšã«é©ããªã
ããšã瀺ããŠããã å®æœäŸ 13 Tcâ99mâMAGGâã¢ã¹ãã©ã®ã³ã®åæãã
ã³è èã«ããå蟌㿠Tcâ99mâMAGGâã¢ã¹ãã©ã®ã³ã¯åèšåå¿
åŒãªãã³ã«å®æœäŸïŒããã³ïŒã«èšèŒã®äžè¬åæå·¥
çšã«åŸã€ãŠè£œé ããããã ãå®æœäŸïŒã®ã°ãªã·ã«
ã°ãªã·ã«ã°ãªã·ã³ã®ä»£ããã«ã°ãªã·ã«ã°ãªã·ã«ã¢
ã¹ãã©ã®ã³ã䜿çšããã Tcâ99mâMAGGâã¢ã©ãã©ã®ã³ã¯ïŒã€ã®å
é¢å¯èœãªãžã¢ã¹ãã¬ãªããŒïŒèšå·âããã³â
ã§åºå¥ããïŒãšããŠååšããããããã®ãžã¢ã¹ã
ã¬ãªããŒTcâ99mâMAGGâã¢ã¹ãã©ã®ã³â
ããã³Tcâ99mâMAGGâã¢ã¹ãã©ã®ã³âã
åé¢ããŠãå®æœäŸïŒã«èšèŒã®æ¹æ³ãšé¡äŒŒããæ¹æ³
ãçšããŠããŠã¹ã«æäžããããããã®ïŒã€ã®åå
ç©ã«é¢ããçç©ååžã®æž¬å®çµæãããããè¡šXIã
ãã³XIIã«ç€ºãã
ãšãã«ã¢ã©ãã³âã®å°¿äžã¬ãã«ã¯ããããâ
131 OIHã®å¯Ÿå¿ã¬ãã«ã®43.9ïŒ ããã³73.5ïŒ ã«ç
ããã€ãã10ããã³120åã§ã®Tcâ99mâ
MAGGâããšãã«ã¢ã©ãã³âã®å°¿äžã¬ãã«ã¯
ããããâ131 OIHã®å¯Ÿå¿ã¬ãã«ã®22.0ããã³
52.3ïŒ ã«çããã€ãããããã®äœãçŸåçã¯ãã
ããã®ååç©ã®ææéãçš®ã ã®çµç¹ã«å蟌ãŸãã
ããšã瀺ãçç©ååžã®æž¬å®çµæãšå ±ã«ãTcâ
99mâMAGGâããšãã«ã¢ã©ãã³ãäžè¬ã®ã·ã³
ãã°ã©ãã€ãŒå°¿è·¯é 圱æ³ã§ã®æ¥åžžäœ¿çšã«é©ããªã
ããšã瀺ããŠããã å®æœäŸ 13 Tcâ99mâMAGGâã¢ã¹ãã©ã®ã³ã®åæãã
ã³è èã«ããå蟌㿠Tcâ99mâMAGGâã¢ã¹ãã©ã®ã³ã¯åèšåå¿
åŒãªãã³ã«å®æœäŸïŒããã³ïŒã«èšèŒã®äžè¬åæå·¥
çšã«åŸã€ãŠè£œé ããããã ãå®æœäŸïŒã®ã°ãªã·ã«
ã°ãªã·ã«ã°ãªã·ã³ã®ä»£ããã«ã°ãªã·ã«ã°ãªã·ã«ã¢
ã¹ãã©ã®ã³ã䜿çšããã Tcâ99mâMAGGâã¢ã©ãã©ã®ã³ã¯ïŒã€ã®å
é¢å¯èœãªãžã¢ã¹ãã¬ãªããŒïŒèšå·âããã³â
ã§åºå¥ããïŒãšããŠååšããããããã®ãžã¢ã¹ã
ã¬ãªããŒTcâ99mâMAGGâã¢ã¹ãã©ã®ã³â
ããã³Tcâ99mâMAGGâã¢ã¹ãã©ã®ã³âã
åé¢ããŠãå®æœäŸïŒã«èšèŒã®æ¹æ³ãšé¡äŒŒããæ¹æ³
ãçšããŠããŠã¹ã«æäžããããããã®ïŒã€ã®åå
ç©ã«é¢ããçç©ååžã®æž¬å®çµæãããããè¡šXIã
ãã³XIIã«ç€ºãã
ãè¡šã
ãè¡šã
10åããã³120åã§ã®Tcâ99mâMAGGâã¢
ã¹ãã©ã®ã³âã®å°¿äžã¬ãã«ã¯ããããâ131
OIHã®å¯Ÿå¿ã¬ãã«ã®98.9ïŒ ããã³102.2ïŒ ã«çã
ãã€ãã10åããã³120åã§ã®Tcâ99mâ
MAGGâã¢ã¹ãã©ã®ã³âã®å°¿äžã¬ãã«ã¯ãã
ããâ131 OIHã®å¯Ÿå¿ã¬ãã«ã®97.1ïŒ ããã³
103.5ïŒ ã«çããã€ãã ãããã®é«ãçŸåçã¯Tcâ99mâMAGGâã¢
ã¹ãã©ã®ã³ã®ã©ã¡ãã®ãžã¢ã¹ãã¬ãªããŒãã·ã³ã
ã°ã©ãã€ãŒå°¿è·¯é 圱æ³ã«ãããŠïŒ©â131 OIHã®
代æ¿ç©ãšããŠé©åœã§ããããšã瀺ããŠããããŸ
ãããããã®ãžã¢ã¹ãã¬ãªããŒã¯äž¡æ¹ãšãâ
131 OIHã®é©åœãªä»£æ¿ç©ã§ããã®ã§ããžã¢ã¹ã
ã¬ãªããŒãäºãããåé¢ããå¿ èŠããªããããã
ã®åœ¢ã§ã®ãããã®ååç©ã®äœ¿çšã¯ããªãå®çšçã§
ããã å®æœäŸ 14 Tcâ99mâMAGGâã°ã«ã¿ã«é žã®åæããã³
è èã«ããå蟌㿠åèšåå¿åŒãªãã³ã«å®æœäŸïŒããã³ïŒã«èšèŒã®
äžè¬åæå·¥çšã«åŸã€ãŠãTcâ99mâMAGGâã°
ã«ã¿ã«é žã補é ããããã ããå®æœäŸïŒã®ã°ãªã·
ã«ã°ãªã·ã«ã°ãªã·ã³ã®ä»£ããã«ã°ãªã·ã«ã°ãªã·ã«
ã°ã«ã¿ã«é žã䜿çšããã Tcâ99mâMAGGâã°ã«ã¿ã«é žã¯ïŒã€ã®åé¢
å¯èœãªãžã¢ã¹ãã¬ãªããŒïŒèšå·âããã³âã§
åºå¥ããïŒãšããŠååšããããããã®ãžã¢ã¹ãã¬
ãªããŒãåé¢ããŠãåã ãå®æœäŸïŒã«èšèŒã®ãã®
ãšé¡äŒŒããæ¹æ³ã䜿çšããŠããŠã¹ã«æäžãããã
ããã®ååç©ã«é¢ããçç©ååžã®æž¬å®çµæããã
ããè¡šããã³ã«ç€ºãã
ã¹ãã©ã®ã³âã®å°¿äžã¬ãã«ã¯ããããâ131
OIHã®å¯Ÿå¿ã¬ãã«ã®98.9ïŒ ããã³102.2ïŒ ã«çã
ãã€ãã10åããã³120åã§ã®Tcâ99mâ
MAGGâã¢ã¹ãã©ã®ã³âã®å°¿äžã¬ãã«ã¯ãã
ããâ131 OIHã®å¯Ÿå¿ã¬ãã«ã®97.1ïŒ ããã³
103.5ïŒ ã«çããã€ãã ãããã®é«ãçŸåçã¯Tcâ99mâMAGGâã¢
ã¹ãã©ã®ã³ã®ã©ã¡ãã®ãžã¢ã¹ãã¬ãªããŒãã·ã³ã
ã°ã©ãã€ãŒå°¿è·¯é 圱æ³ã«ãããŠïŒ©â131 OIHã®
代æ¿ç©ãšããŠé©åœã§ããããšã瀺ããŠããããŸ
ãããããã®ãžã¢ã¹ãã¬ãªããŒã¯äž¡æ¹ãšãâ
131 OIHã®é©åœãªä»£æ¿ç©ã§ããã®ã§ããžã¢ã¹ã
ã¬ãªããŒãäºãããåé¢ããå¿ èŠããªããããã
ã®åœ¢ã§ã®ãããã®ååç©ã®äœ¿çšã¯ããªãå®çšçã§
ããã å®æœäŸ 14 Tcâ99mâMAGGâã°ã«ã¿ã«é žã®åæããã³
è èã«ããå蟌㿠åèšåå¿åŒãªãã³ã«å®æœäŸïŒããã³ïŒã«èšèŒã®
äžè¬åæå·¥çšã«åŸã€ãŠãTcâ99mâMAGGâã°
ã«ã¿ã«é žã補é ããããã ããå®æœäŸïŒã®ã°ãªã·
ã«ã°ãªã·ã«ã°ãªã·ã³ã®ä»£ããã«ã°ãªã·ã«ã°ãªã·ã«
ã°ã«ã¿ã«é žã䜿çšããã Tcâ99mâMAGGâã°ã«ã¿ã«é žã¯ïŒã€ã®åé¢
å¯èœãªãžã¢ã¹ãã¬ãªããŒïŒèšå·âããã³âã§
åºå¥ããïŒãšããŠååšããããããã®ãžã¢ã¹ãã¬
ãªããŒãåé¢ããŠãåã ãå®æœäŸïŒã«èšèŒã®ãã®
ãšé¡äŒŒããæ¹æ³ã䜿çšããŠããŠã¹ã«æäžãããã
ããã®ååç©ã«é¢ããçç©ååžã®æž¬å®çµæããã
ããè¡šããã³ã«ç€ºãã
ãè¡šã
ãè¡šã
10åããã³120åã§ã®Tcâ99mâMAGGâã°
ã«ã¿ã«é žâã®å°¿äžã¬ãã«ã¯ããããâ131
OIHã®å¯Ÿå¿ã¬ãã«ã®73.0ïŒ ããã³99.8ïŒ ã«çãã
ã€ãã10åããã³120åã§ã®Tcâ99mâMAGG
âã°ã«ã¿ã«é žâã®å°¿äžã¬ãã«ã¯ããããâ
131 OIHã®å¯Ÿå¿ã¬ãã«ã®88.6ïŒ ããã³98.8ïŒ ã«ç
ããã€ãããããã®çµæã¯ãã®ååç©ãâ131
OIHã®ä»£æ¿ç©ãšããŠèæ ®ããããããšã瀺ããŠ
ããã å®æœäŸ 15 ãã®ä»ã®Tcâ99mN3Sç³»ååç©ã®åæ åèšåå¿åŒãªãã³ã«å®æœäŸïŒããã³ïŒã«èšèŒã
ããTcâ99mâMAGGã®äžè¬åæå·¥çšã«åŸã€
ãŠãæ¬çºæç¯å²å ã®N3Sç³»ååç©ã«å å«ãããã
ã®ä»ã®Tcâ99mååç©ãåæãããäŸãã°ã次
ã®äžè¬åŒïŒ ïŒåŒäžãã¯âCH2CH2CO2Hã§ããïŒ ã§è¡šããããTcâ99mååç©ãåæããããã®
ååç©ã¯å®æœäŸïŒã®ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ã®
代ããã«
NH2CH2CONHCH2CONHCH2CH2CO2Hã䜿çš
ããŠè£œé ãããã Tcâ99mâMAGGã®å Žåã®è©Šéšçµæã«åºã¥ã
ãšããã®ååç©ãææã®åžåçã瀺ãããšãäºæ
ãããã å®æœäŸ 16 å®æœäŸ15ã«èšèŒã®äžè¬åŒã«ãããŠïŒ¹ãâCH
ïŒCH2CH3ïŒCO2Hã§ããå¥ã®Tcâ99mååç©ãã
åèšåå¿åŒãªãã³ã«å®æœäŸïŒããã³ïŒã«èšèŒã®äž
è¬åæå·¥çšã«åŸã€ãŠåæããããã ãããã®å Žå
ã®åºçºãªã¬ã³ãã¯NH2CH2CONHCH2CONHCH
ïŒCH2CH3ïŒCO2Hã§ããã Tcâ99mâMAGGGã®å Žåã®è©Šéšçµæã«åºã¥
ããšããã®ååç©ãææã®è èåžåçã瀺ãããš
ãäºæãããã å®æœäŸ 17 å®æœäŸ15ã«èšèŒã®äžè¬åŒã«ãããŠïŒ¹ãâ
CH2CONH2ã§ããå¥ã®Tcâ99mååç©ããåèš
åå¿åŒãªãã³ã«å®æœäŸïŒããã³ïŒã«èšèŒã®äžè¬å
æå·¥çšã«åŸã€ãŠåæããããã ãããã®å Žåã®åº
çºãªã¬ã³ãã¯
NH2CH2CONHCH2CONHCH2CONH2ã§ããã Tcâ99mâMAGGGã®è©Šéšçµæã«åºã¥ããšã
ãã®ååç©ãææã®è èåžåçŽ ã瀺ãããšãäºæ
ãããã å®æœäŸ 18 Tcâ99mN4ç³»ååç©ã®åæ å ã«åæãããN3Sç°ç³»ãæããTcâ99må
åç©ã«å ããŠãN4ç³»ãå å«ããTcâ99mé¢é£å
åç©ãåæããããšãå¯èœã§ãããäŸãã°ã次ã®
äžè¬åŒïŒ ïŒåŒäžãã¯ã¯âCH2CO2Hã§ããïŒ ã§è¡šããããæ°èŠTcâ99mååç©ããåèšåå¿
åŒããã³å®æœäŸïŒã«èšèŒã®äžè¬åæå·¥çšãçšããŠ
åæããããã ãããã®å Žåã¯ãªã¬ã³ã
NH2CO2CONHCH2CONHCH2CONHCH2CO2
ïŒã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ïŒãéã
ã¯ãããŠã é žãããªãŠã ãšåå¿ãããã åŸãããååç©Tcâ99mâGGGGãå®æœäŸïŒ
ã«èšèŒã®ãã®ãšé¡äŒŒã®æ¹æ³ãçšããŠããŠã¹ã«æäž
ããã泚å°ã®10ååŸããã³120ååŸã§ã®çç©ååž
ã®æž¬å®çµæãè¡šã«ç€ºãã
ã«ã¿ã«é žâã®å°¿äžã¬ãã«ã¯ããããâ131
OIHã®å¯Ÿå¿ã¬ãã«ã®73.0ïŒ ããã³99.8ïŒ ã«çãã
ã€ãã10åããã³120åã§ã®Tcâ99mâMAGG
âã°ã«ã¿ã«é žâã®å°¿äžã¬ãã«ã¯ããããâ
131 OIHã®å¯Ÿå¿ã¬ãã«ã®88.6ïŒ ããã³98.8ïŒ ã«ç
ããã€ãããããã®çµæã¯ãã®ååç©ãâ131
OIHã®ä»£æ¿ç©ãšããŠèæ ®ããããããšã瀺ããŠ
ããã å®æœäŸ 15 ãã®ä»ã®Tcâ99mN3Sç³»ååç©ã®åæ åèšåå¿åŒãªãã³ã«å®æœäŸïŒããã³ïŒã«èšèŒã
ããTcâ99mâMAGGã®äžè¬åæå·¥çšã«åŸã€
ãŠãæ¬çºæç¯å²å ã®N3Sç³»ååç©ã«å å«ãããã
ã®ä»ã®Tcâ99mååç©ãåæãããäŸãã°ã次
ã®äžè¬åŒïŒ ïŒåŒäžãã¯âCH2CH2CO2Hã§ããïŒ ã§è¡šããããTcâ99mååç©ãåæããããã®
ååç©ã¯å®æœäŸïŒã®ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ã®
代ããã«
NH2CH2CONHCH2CONHCH2CH2CO2Hã䜿çš
ããŠè£œé ãããã Tcâ99mâMAGGã®å Žåã®è©Šéšçµæã«åºã¥ã
ãšããã®ååç©ãææã®åžåçã瀺ãããšãäºæ
ãããã å®æœäŸ 16 å®æœäŸ15ã«èšèŒã®äžè¬åŒã«ãããŠïŒ¹ãâCH
ïŒCH2CH3ïŒCO2Hã§ããå¥ã®Tcâ99mååç©ãã
åèšåå¿åŒãªãã³ã«å®æœäŸïŒããã³ïŒã«èšèŒã®äž
è¬åæå·¥çšã«åŸã€ãŠåæããããã ãããã®å Žå
ã®åºçºãªã¬ã³ãã¯NH2CH2CONHCH2CONHCH
ïŒCH2CH3ïŒCO2Hã§ããã Tcâ99mâMAGGGã®å Žåã®è©Šéšçµæã«åºã¥
ããšããã®ååç©ãææã®è èåžåçã瀺ãããš
ãäºæãããã å®æœäŸ 17 å®æœäŸ15ã«èšèŒã®äžè¬åŒã«ãããŠïŒ¹ãâ
CH2CONH2ã§ããå¥ã®Tcâ99mååç©ããåèš
åå¿åŒãªãã³ã«å®æœäŸïŒããã³ïŒã«èšèŒã®äžè¬å
æå·¥çšã«åŸã€ãŠåæããããã ãããã®å Žåã®åº
çºãªã¬ã³ãã¯
NH2CH2CONHCH2CONHCH2CONH2ã§ããã Tcâ99mâMAGGGã®è©Šéšçµæã«åºã¥ããšã
ãã®ååç©ãææã®è èåžåçŽ ã瀺ãããšãäºæ
ãããã å®æœäŸ 18 Tcâ99mN4ç³»ååç©ã®åæ å ã«åæãããN3Sç°ç³»ãæããTcâ99må
åç©ã«å ããŠãN4ç³»ãå å«ããTcâ99mé¢é£å
åç©ãåæããããšãå¯èœã§ãããäŸãã°ã次ã®
äžè¬åŒïŒ ïŒåŒäžãã¯ã¯âCH2CO2Hã§ããïŒ ã§è¡šããããæ°èŠTcâ99mååç©ããåèšåå¿
åŒããã³å®æœäŸïŒã«èšèŒã®äžè¬åæå·¥çšãçšããŠ
åæããããã ãããã®å Žåã¯ãªã¬ã³ã
NH2CO2CONHCH2CONHCH2CONHCH2CO2
ïŒã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã«ã°ãªã·ã³ïŒãéã
ã¯ãããŠã é žãããªãŠã ãšåå¿ãããã åŸãããååç©Tcâ99mâGGGGãå®æœäŸïŒ
ã«èšèŒã®ãã®ãšé¡äŒŒã®æ¹æ³ãçšããŠããŠã¹ã«æäž
ããã泚å°ã®10ååŸããã³120ååŸã§ã®çç©ååž
ã®æž¬å®çµæãè¡šã«ç€ºãã
ãè¡šã
10åããã³120åã§ã®Tcâ99mâGGGGã®å°¿äž
ã¬ãã«ã¯ããããâ131 OIHã®å¯Ÿå¿ã¬ãã«ã®
89.4ïŒ ããã³96.7ïŒ ã«çããããã®ååç©ãâ
131 OIHã®ä»£æ¿ç©ãšãªãåŸãããšã瀺ããŠããã å®æœäŸ 19 ç°ç³»ã«ããã€ãã®æ§é å€åãæããä»ã®Tcâ
99mååç©ã補é ããããšãã§ãããäŸãã°ã次
ã®äžè¬åŒïŒ ã§è¡šããããååç©ã¯ææã®è èåžåçã瀺ãã
ãšãäºæããããäžèšäžè¬åŒã«ãããŠïŒžãã§ã
ããâCH2CO2Hã§ããååç©ã¯ãåèšåå¿åŒ
ãªãã³ã«å®æœäŸïŒããã³ïŒã«èšèŒã®äžè¬åæå·¥çš
ã«åŸããã€
NH2CH2CH2NHCOCONHCH2CO2Hããåºçº
ããããšã«ããåæã§ããã å®æœäŸ 20 次ã®äžè¬åŒïŒ ïŒåŒäžãã¯ïŒ³ã§ãããã¯âCHCH3CO2H
ã§ããïŒ ã§è¡šããããä»ã®Tcâ99mååç©ã¯ãåèšåå¿
åŒããã³å®æœäŸïŒã®äžè¬åæå·¥çšã«åŸã
C6H5COSCH2CH2NHCOCONHCH2CONHCH
ïŒïŒ£ïŒ¯ïŒïŒšãšéãã¯ãããŠã é žãããªãŠã ãšãå
å¿ãããããšã«ããåæãããã Tcâ99mâMAGGGãçšããŠè¡ã€ãè©Šéšã®çµ
æã«åºã¥ããšããã®ååç©ãææã®è èåžåçã
瀺ãããšãäºæãããã å®æœäŸ 21 次ã®äžè¬åŒïŒ ïŒåŒäžãã¯ïŒ³ã§ãããã¯âCH2CH2CO2H
ã§ããïŒ ã§è¡šããããå¥ã®Tcâ99mååç©ã¯ãåèšåå¿
åŒããã³å®æœäŸïŒã®äžè¬åæå·¥çšã«åŸã
CH3COSCH2CH2NHCH2CONHCH2CONHCH2
ïŒïŒ£ïŒ¯ïŒïŒšãšéãã¯ãããŠã é žãããªãŠã ãšãå
å¿ãããããšã«ããåæãããã Tcâ99mâMAGGãçšããŠè¡ã€ãè©Šéšã®çµæ
ã«åºã¥ããšããã®ååç©ãææã®è èåžåçã瀺
ãããšãäºæãããã å®æœäŸ 22 次ã®äžè¬åŒïŒ ïŒåŒäžãã¯ïŒ®ã§ãããã¯âCH2CO2Hã§ã
ãïŒ ã§è¡šããããå¥ã®Tcâ99mååç©ã¯ãåèšåå¿
åŒããã³å®æœäŸïŒã®äžè¬åæå·¥çšã«åŸã€ãŠ
H2NCH2CH2NHCH2CH2NHCOCONHCH2CH2
ãšéãã¯ãããŠã é žãããªãŠã ãšãåå¿ããã
ããšã«ããåæãããã Tcâ99mâMAGGGãçšããŠè¡ã€ãè©Šéšã®çµ
æã«åºã¥ããšããã®ååç©ãææã®è èåžåçã
瀺ãããšãäºæãããã åè¿°ã®ããšãããæ¬çºæã®æ°èŠTcâ99måå
ç©ã¯ãããã®åªããè èåžåçãªãã³ã«ç°æ§ã®ã
ãšãäžå©ãªæ§è³ªã®åé¿ããã«ã·ã³ãã°ã©ãã€ãŒå°¿
è·¯é 圱æ³ã«ãããã€ã¡ãŒãžã³ã°è¬å€ãšããŠæçšã§
ããããšãç解ãããã§ããããããã«ãæ··åå·¥
çšãšå ç±å·¥çšä»¥å€ã¯äœãå¿ èŠãšããªããããã®åœ¢
ã§ãããã®Tcâ99mååç©ã®åé§äœãæäŸã§ã
ãããšã¯ãTcâ99mã®æŸå°æ§æšèãšããŠã®äœ¿çš
ãéåžžã«å®çšåãªãããããã®ã§ããã æ¬çºæã¯ãã®ç²Ÿç¥ãŸãã¯æ¬è³ªçç¹åŸŽããéžè±ã
ãããšãªãä»ã®ç¹å®åœ¢äœã«å ·äœåããããšãã§ã
ããå ã«è¿°ã¹ãå®æœæ æ§ã¯å šãŠã®ç¹ã«ãããŠäŸç€º
ãšããŠã®ã¿èããããã¹ã§ãã§ãããäœãå¶éã
äžãããã®ã§ã¯ãªããåŸã€ãŠãæ¬çºæã®ç¯å²ã¯å
ã®èšè¿°ããããããç¹èš±è«æ±ã®ç¯å²ã«ç€ºãããã
ãã®ç¹èš±è«æ±ã®ç¯å²ãšåçã®ç¯å²ããã³æå³ã«å«
ãŸããå šãŠã®å€æŽã¯ãæ¬çºæã®ç¯å²ã«å å«ããã
ã¹ãã§ããã
ã¬ãã«ã¯ããããâ131 OIHã®å¯Ÿå¿ã¬ãã«ã®
89.4ïŒ ããã³96.7ïŒ ã«çããããã®ååç©ãâ
131 OIHã®ä»£æ¿ç©ãšãªãåŸãããšã瀺ããŠããã å®æœäŸ 19 ç°ç³»ã«ããã€ãã®æ§é å€åãæããä»ã®Tcâ
99mååç©ã補é ããããšãã§ãããäŸãã°ã次
ã®äžè¬åŒïŒ ã§è¡šããããååç©ã¯ææã®è èåžåçã瀺ãã
ãšãäºæããããäžèšäžè¬åŒã«ãããŠïŒžãã§ã
ããâCH2CO2Hã§ããååç©ã¯ãåèšåå¿åŒ
ãªãã³ã«å®æœäŸïŒããã³ïŒã«èšèŒã®äžè¬åæå·¥çš
ã«åŸããã€
NH2CH2CH2NHCOCONHCH2CO2Hããåºçº
ããããšã«ããåæã§ããã å®æœäŸ 20 次ã®äžè¬åŒïŒ ïŒåŒäžãã¯ïŒ³ã§ãããã¯âCHCH3CO2H
ã§ããïŒ ã§è¡šããããä»ã®Tcâ99mååç©ã¯ãåèšåå¿
åŒããã³å®æœäŸïŒã®äžè¬åæå·¥çšã«åŸã
C6H5COSCH2CH2NHCOCONHCH2CONHCH
ïŒïŒ£ïŒ¯ïŒïŒšãšéãã¯ãããŠã é žãããªãŠã ãšãå
å¿ãããããšã«ããåæãããã Tcâ99mâMAGGGãçšããŠè¡ã€ãè©Šéšã®çµ
æã«åºã¥ããšããã®ååç©ãææã®è èåžåçã
瀺ãããšãäºæãããã å®æœäŸ 21 次ã®äžè¬åŒïŒ ïŒåŒäžãã¯ïŒ³ã§ãããã¯âCH2CH2CO2H
ã§ããïŒ ã§è¡šããããå¥ã®Tcâ99mååç©ã¯ãåèšåå¿
åŒããã³å®æœäŸïŒã®äžè¬åæå·¥çšã«åŸã
CH3COSCH2CH2NHCH2CONHCH2CONHCH2
ïŒïŒ£ïŒ¯ïŒïŒšãšéãã¯ãããŠã é žãããªãŠã ãšãå
å¿ãããããšã«ããåæãããã Tcâ99mâMAGGãçšããŠè¡ã€ãè©Šéšã®çµæ
ã«åºã¥ããšããã®ååç©ãææã®è èåžåçã瀺
ãããšãäºæãããã å®æœäŸ 22 次ã®äžè¬åŒïŒ ïŒåŒäžãã¯ïŒ®ã§ãããã¯âCH2CO2Hã§ã
ãïŒ ã§è¡šããããå¥ã®Tcâ99mååç©ã¯ãåèšåå¿
åŒããã³å®æœäŸïŒã®äžè¬åæå·¥çšã«åŸã€ãŠ
H2NCH2CH2NHCH2CH2NHCOCONHCH2CH2
ãšéãã¯ãããŠã é žãããªãŠã ãšãåå¿ããã
ããšã«ããåæãããã Tcâ99mâMAGGGãçšããŠè¡ã€ãè©Šéšã®çµ
æã«åºã¥ããšããã®ååç©ãææã®è èåžåçã
瀺ãããšãäºæãããã åè¿°ã®ããšãããæ¬çºæã®æ°èŠTcâ99måå
ç©ã¯ãããã®åªããè èåžåçãªãã³ã«ç°æ§ã®ã
ãšãäžå©ãªæ§è³ªã®åé¿ããã«ã·ã³ãã°ã©ãã€ãŒå°¿
è·¯é 圱æ³ã«ãããã€ã¡ãŒãžã³ã°è¬å€ãšããŠæçšã§
ããããšãç解ãããã§ããããããã«ãæ··åå·¥
çšãšå ç±å·¥çšä»¥å€ã¯äœãå¿ èŠãšããªããããã®åœ¢
ã§ãããã®Tcâ99mååç©ã®åé§äœãæäŸã§ã
ãããšã¯ãTcâ99mã®æŸå°æ§æšèãšããŠã®äœ¿çš
ãéåžžã«å®çšåãªãããããã®ã§ããã æ¬çºæã¯ãã®ç²Ÿç¥ãŸãã¯æ¬è³ªçç¹åŸŽããéžè±ã
ãããšãªãä»ã®ç¹å®åœ¢äœã«å ·äœåããããšãã§ã
ããå ã«è¿°ã¹ãå®æœæ æ§ã¯å šãŠã®ç¹ã«ãããŠäŸç€º
ãšããŠã®ã¿èããããã¹ã§ãã§ãããäœãå¶éã
äžãããã®ã§ã¯ãªããåŸã€ãŠãæ¬çºæã®ç¯å²ã¯å
ã®èšè¿°ããããããç¹èš±è«æ±ã®ç¯å²ã«ç€ºãããã
ãã®ç¹èš±è«æ±ã®ç¯å²ãšåçã®ç¯å²ããã³æå³ã«å«
ãŸããå šãŠã®å€æŽã¯ãæ¬çºæã®ç¯å²ã«å å«ããã
ã¹ãã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ æ¬¡åŒïŒ åŒäžãã¯ïŒ³ãŸãã¯ïŒ®ã§ããïŒïŒ¹ã¯âã§ã
ããã ãããã¯ãåŒã ïŒããã§R1ã¯âïŒâCH3ïŒãŸãã¯âCH2CH3
ã§ããïŒR2ã¯âïŒâCH2CO2HïŒâCH2CONH2ïŒ
âCH2CH2CO2HïŒâCH2CH2CONH2ïŒâCH3ïŒâ
CH2CH3ïŒãŸãã¯âCH2OHã§ããïŒãããŠïŒºã¯
âïŒâCO2HïŒâCONH2ïŒâSO3HïŒâSO2NH2ïŒ
ãŸãã¯âCONHCH2CO2Hã§ããïŒã§ããïŒãã
ãŠTcã¯Tcâ99mã§ãã ã§è¡šãããååç©ãŸãã¯ãã®æ°Žæº¶æ§å¡©ã ïŒ ïŒžãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®å
åç©ã ïŒ ïŒ¹ãâCH2CO2Hã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
é èšèŒã®ååç©ã ïŒ ïŒ¹ãâCHCH3CO2HïŒ âCHïŒCH2CONH2ïŒCO2HïŒãŸã㯠âCHïŒCH2CH2CONH2ïŒCOOHã§ããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ (a) äžè¬åŒïŒ NH2CH2CONHCH2COHNY åŒäžãã¯âã§ãããã ãããã¯ãåŒã ïŒããã§R1ã¯âïŒâCH3ïŒãŸãã¯âCH2CH3
ã§ããïŒR2ã¯âïŒâCH2CO2HïŒâCH2CONH2ïŒ
âCH2CH2CO2HïŒâCH2CH2CONH2ïŒâCH3ïŒâ
CH2CH3ïŒãŸãã¯âCH2OHã§ããïŒãããŠïŒºã¯
âïŒâCO2HïŒâCONH2ïŒâSO3HïŒâSO2NH2ã
ãŸãã¯âCONHCH2CO2Hã§ããïŒã§ãã ã®ååç©ãå¡©åã¯ãã«ã¢ã»ãã«ãšåå¿ããïŒ (b) å·¥çš(a)ã®çæç©ãé©åœãªããªå®æ¯éŠé žå¡©ãšå
å¿ããïŒãã㊠(c) å·¥çš(b)ã®çæç©ãé©åœãªéãã¯ãããŠã é žå¡©
ãšåå¿ãããïŒ ããšãããªãäžè¬åŒïŒ ã§è¡šãããååç©ã®è£œé æ¹æ³ã ïŒ ïŒ¹ãâCH2CO2Hã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
é èšèŒã®æ¹æ³ã ïŒ ïŒ¹ãâCHCH3CO2HïŒ âCHïŒCH2CONH2ïŒCO2HïŒãŸã㯠âCHïŒCH2CH2CONH2ïŒCOOHã§ããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒ å·¥çš(b)ã®çæç©ãéãã¯ãããŠã é žå¡©ãšåå¿
ãããå·¥çšãã第äžé«ã€ãªã³ããã³é©åœãªäº€æãª
ã¬ã³ãäžéäœã®ååšäžã«å·¥çš(b)ã®çæç©ãéãã¯
ãããŠã é žå¡©ãšæ··åãããã®æ··åç©ãå ç±ããã
ãšã«ããéæãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
æ¹æ³ã ïŒ é©åœãªäº€æãªã¬ã³ãäžéäœãã¢ã»ããŒããã°
ãªã·ã³ãã·ãã¬ãŒããããããŒããã°ã«ã³ããŒ
ãããããã¹ããšãŒããã¿ã«ãã¬ãŒãããã¬ãšãŒ
ããã©ã¯ããŒããããããã·ã€ãœããã¬ãŒãã
âã¡ãã«ïŒ®ïŒNâ²âãã¹ïŒïŒâããããã·ãšãã«ïŒ
ãšãã¬ã³ãžã¢ãã³ãŸãã¯ã°ã«ã³ãããããŒãã§ã
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒïŒ ãâCH2COOHã§ããç¹èš±è«æ±ã®ç¯å²
第ïŒé èšèŒã®æ¹æ³ã ïŒïŒ ãâCHCH3CO2HïŒ âCHïŒCH2CONH2ïŒCO2HïŒãŸã㯠âCHïŒCH2CH2CONH2ïŒCOOHã§ããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62409884A | 1984-06-25 | 1984-06-25 | |
US733481 | 1985-05-14 | ||
US624098 | 1985-05-14 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4183915A Division JPH0749406B2 (ja) | 1984-06-25 | 1992-07-10 | æ°èŠãã¬ãŒãå€ |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6140295A JPS6140295A (ja) | 1986-02-26 |
JPH0482159B2 true JPH0482159B2 (ja) | 1992-12-25 |
Family
ID=24500647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13887085A Granted JPS6140295A (ja) | 1984-06-25 | 1985-06-25 | è æ©èœæž¬å®çšã®æŸå°èœæšèãã¯ãããŠã ãã¬âãé¡ |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPS6140295A (ja) |
ZA (1) | ZA854152B (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5959852A (ja) * | 1982-09-30 | 1984-04-05 | Toshiba Corp | è£ é£Ÿçšå |
US4980147A (en) * | 1984-06-25 | 1990-12-25 | University Of Utah Research Foundation | Radiolabeled technetium chelates for use in renal function determinations |
-
1985
- 1985-06-25 JP JP13887085A patent/JPS6140295A/ja active Granted
- 1985-08-03 ZA ZA854152A patent/ZA854152B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA854152B (en) | 1986-02-26 |
JPS6140295A (ja) | 1986-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2530112B2 (ja) | è æ©èœæž¬å®çšã®æŸå°èœæšèãã¯ãããŠã ãã¬âããå«ãããã | |
JP3129431B2 (ja) | è æ©èœæ€æ»ã®ããã®ãã¯ãããŠã âïŒïŒïœé¯ååç© | |
Chervu et al. | Radiopharmaceuticals for hepatobiliary imaging | |
US4673562A (en) | Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents | |
JPS63295549A (ja) | ãšã¹ãã«çœ®æãžã¢ãã³ãžããªãŒã«é¡ããã³ãããã®æŸå°ç·æšèé¯ååç© | |
US5245018A (en) | Process for preparing a radiopharmaceutical composition | |
DE4301871A1 (de) | Neue Mittel zur Diagnose von GefÀÃerkrankungen | |
Lipowska et al. | Re (CO) 3 ([18F] FEDA), a novel 18F PET renal tracer: radiosynthesis and preclinical evaluation | |
Efange et al. | Technetium-99m bis (aminoethanethiol) complexes with amine sidechainsâpotential brain perfusion imaging agents for SPECT | |
HUT73665A (en) | Bifunctional-chelating agents braked with calcogene atoms, pharmaceutical compositions containing them , and use of these compositions in radio- diagnosis and radiotherapy | |
EP0053347B1 (en) | Radioactive diagnostic agent and non-radioactive carrier therefor | |
Lipowska et al. | Al18F-NODA-butyric acid: biological evaluation of a new PET renal radiotracer | |
Shi et al. | [68Ga] Ga-HBED-CC-DiAsp: A new renal function imaging agent | |
Chervu et al. | Technetium-99m-labeled p-aminohippuric acid analog: a new renal agent: concise communication | |
EP1719754A1 (en) | DTPA derivatives and metal complexes therof, and radiation source and contrast agent including the metal complexes | |
JPH0482159B2 (ja) | ||
CA2728343A1 (en) | 18f-labelled three- and four-carbon acids for pet imaging | |
KR20010092163A (ko) | êžë£šìœì€ ì ë첎ì ë°©ì¬ì± ëìììê° íì§ë ì°©íí©ë¬Œ ë°ìŽë¥Œ ìì°íêž° ìí ì¡°ì±ë¬ŒìŽ í¬íšë í€íž | |
WO2016145156A1 (en) | Metal tricarbonyl complexes comprising substituted iminodiactic acid ligands and uses as radioisotope tracers | |
CA1317066C (en) | Ligand for forming radiolabeled technetium chelates for use in renal function determinations | |
JP3704172B2 (ja) | ãã¬ãŒã圢ææ§ãã§ãã«ãžã¢ãããžããªãŒã«èªå°äœå ã³ãã®çšé | |
KR102269315B1 (ko) | ì 늜ì ìì ìì ëë ì¹ë£ë¥Œ ìí ëììì íì§ íí©ë¬Œ | |
Chopra | 99m Tc-Tricarbonylâlabeled aspartic-N-monoacetic acid (ASMA)[99m Tc](CO) 3 (ASMA) | |
Testa | 17 Radiopharmaceuticals | |
JPS62207282A (ja) | ãã¯ãããŠã âïŒïŒïœæšèã€ãè æ©èœèšºæå€ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |